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Integrative Summary 
 
 
 
 
The integrative summary provides an introduction to the research evaluation report 
in the form of a case study, research area, presents the objective and concepts. 
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i. Background of Research Case Study 
The pharmaceutical industry must worry about managing pharmaceutical waste 
as it poses a health risk to human beings and its presence in the environment 
can also contribute to loss of biodiversity. Ngwuluka, Ochekpe, and Odumosu 
(2011: 11259) state that “Pharmaceuticals, though used to treat and manage 
diseases, are poisons, which justify the growing concerns about their presence in 
the environment.”  Various forms of pharmaceutical waste exist, Ngwuluka et al. 
(2011) identified the following forms of pharmaceutical waste: Expired dosage 
forms, non-reworkable formulations, spilled pharmaceuticals, rejected active 
pharmaceutical ingredients, expired active pharmaceutical ingredients, and 
wastewater resulting from the water used for process operations during 
manufacturing and could come from the water used to clean equipment, pipes 
and floors, and would contain amongst other materials, chemicals and active 
pharmaceutical ingredients (APIs). 
A review on the pharmaceutical industry and the progress they have made in 
environmental management by generating health, safety and environmental 
programs, preventing pollution, waste minimization, recycling and reusing 
materials, investing in projects and facilities to ensure environmental 
sustainability have been established (Berry & Rondinelli, 2000). 
Dr. Reddy’s Laboratories is an Indian based pharmaceutical company which 
imports, markets and sells medicines in South Africa.  Dr. Reddy’s has plans to 
set up a manufacturing plant in South Africa.  The purpose of this study is to 
research waste management practices at Dr. Reddy’s plant in India and to draw 
parallels between India’s and South Africa’s waste legislation.  This is to enable 
Dr. Reddy’s to review all aspects of its waste management systems, in order to 
revise where necessary and to improve the overall achievement of its waste 
management objectives in order to become a more sustainable organisation and 
to meet South African Waste legislation before setting up a plant in South Africa. 
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ii. Objective of the Evaluation Report 
The purpose of this research is to evaluate and analyse the development and 
implementation of a waste management system in a pharmaceutical company, 
specifically Dr. Reddy’s Laboratories. This is primarily to enable the company to 
review and analyse all aspects of waste management pertaining to pharmaceutical 
manufacturing and to revise or improve where necessary to ensure adherence to 
waste regulations as outlined by government. The following research goals have 
been also been identified: 
 To identify and describe waste management practices at Dr. Reddy’s 
Laboratories, on the inherent assumption by the researcher that the company 
has a successful waste management strategy that would need to be reviewed 
to identify areas of improvement before expanding manufacturing facilities into 
South Africa. 
 To evaluate, assess and compare similarities and/or differences between the 
identified South African Legislation for Waste Management with those 
identified during research conducted at Dr. Reddy’s Laboratories. 
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iii. Importance of the Research Conducted 
Waste Management is important in that it not only removes from the environment, 
substances that can be harmful to humans and animals but it also enables an 
organisation to be more sustainable.  According to Seadon (2010: i) “Integrated 
waste management is considered from a systems’ approach, with a particular 
emphasis on advancing sustainability”. 
The study will provide guidance to senior management, shop floor managers and 
employees who work in Dr. Reddy’s manufacturing plants as well as overall 
employees at Dr. Reddy’s on how to successfully implement a Waste Management 
programme to enhance sustainability at the organisation and realise the benefits to 
the organisation of being more sustainable.  Weybrecht (2010) identified the 
following benefits that companies could gain by adopting sustainable waste 
management practices: reduced costs, resource preservation, keeping up with 
legislation, enhanced reputation, business differentiation from competitors, and 
attraction and retention of quality employees, and customer need satisfaction 
amongst many other benefits. 
This research needs to address the gap in analysing waste management practices 
(with more emphasis on waste treatment, waste minimisation, re-use, recycling and 
disposal), and implementation and understanding of waste management in the 
pharmaceutical industry as prior research was done mostly in other chemical 
industries and not to a large scale in the pharmaceutical industry.  South African 
Waste Legislation, Indian Waste Legislation (as Dr. Reddy’s is based in India), as 
well as International Pharmaceutical Waste Management Guidelines, and 
International Pharmaceutical Good Manufacturing Practices provide a framework 
and benchmark of leading pharmaceutical waste management practices that can 
guide Dr. Reddy’s Laboratories’ leadership into integrating their waste management 
practices into their plans of setting up a manufacturing plant in South Africa. 
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iv. Research Methodology 
This is evaluation research in the form of a case study and the data collection 
method employed is the conduction of a survey through questionnaires. 
The evaluation research also involves a document analysis of the organisation’s 
2011 and 2012 annual reports, Dr. Reddy’s 2010 Sustainability Report as well as 
literature compiled by the organisation’s Corporate Communications Division.  The 
research would also include review of existing literature on waste management. 
v. Structure of Dissertation  
This dissertation consists of three sections. 
Section 1: The Evaluation Report 
The section introduces the research area, provides the objectives of the research, 
provides contextual background information and describes the rationale for 
conducting the research.  This section further describes Dr. Reddy’s waste 
management practice as outlined in relevant company documentation; it is also 
intended to highlight the specific waste management processes that were followed in 
the formulation and implementation of the waste management strategy. 
This section further describes the sample and presents the results of the survey, 
where the results are collated and reviewed in the context of the criteria set in the 
South African Waste Legislation, Indian Waste Legislation, as well as in International 
Pharmaceutical Waste Management Guidelines, and International Pharmaceutical 
Good Manufacturing Practices. 
The overall findings of this case study suggest that although management at 
Dr. Reddy’s are satisfied with waste management practices and results achieved at it 
manufacturing plant, there is however dissatisfaction amongst employees who 
believe the organisation has not successfully disseminated information and 
sufficiently trained them on waste management policies, processes and practices.  
There is therefore a desire amongst employees to be trained and to see the 
company improve on its waste management processes, this desire is a very 
important attribute as it indicates that employees at Dr. Reddy understand and are 
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committed to the importance of waste management.  Future research should be 
conducted to measure the legal impact of non-compliance to legislation governing 
waste management in the pharmaceutical company. 
Section 2: Literature Review 
The objective of the literature review is to provide a critical assessment and 
evaluation of previous research in the field of waste management in general as prior 
research was done mostly in other industries and not to a large scale in the 
pharmaceutical industry.  The literature review evaluates the key elements of an 
effective waste management strategy implementation and is followed by a review of 
literature pertaining to the description of Pharmaceutical waste. 
Section 3: Research Methodology 
This section presents a description of how the work in this research was conducted.  
It presents the research process followed in compiling this case study, represented 
by the aims and objectives, research methodology and design, data collection 
techniques and data analysis. 
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1 Section 1 – Dr. Reddy’s Laboratories 
Evaluation Report. 
 
 
 
The section introduces the research area, provides the objectives of the research, 
provides contextual background information and describes the rationale for 
conducting the research.  This section further describes Dr. Reddy’s waste 
management practice as outlined in relevant company documentation and presents 
the results of the survey conducted amongst Dr. Reddy’s employees. 
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1.1 Abstract and Introduction 
Dr. Reddy’s Laboratories is an Indian based pharmaceutical company which imports, 
markets and sells medicines in South Africa.  Dr. Reddy’s has plans to set up a 
manufacturing plant in South Africa, the purpose of this study is to research waste 
management practices at Dr. Reddy’s plant in India and to draw parallels between 
India’s and South Africa’s waste legislation.  This is to enable Dr. Reddy’s to review 
all aspects of its waste management systems, in order to revise where necessary 
and to improve the overall achievement of its waste management objectives in order 
to become a more sustainable organisation and to meet South African Waste 
legislation before setting up a plant in South Africa. 
This research needs to address the gap in analysing waste management practices 
(with more emphasis on waste treatment, waste minimisation, re-use, recycling and 
disposal), and implementation and understanding of waste management in the 
pharmaceutical industry as prior research was done mostly in other chemical 
industries and not to a large scale in the pharmaceutical industry.  South African 
Waste Legislation, Indian Waste Legislation (as Dr. Reddy’s is based in India), as 
well as International Pharmaceutical Waste Management Guidelines, and 
International Pharmaceutical Good Manufacturing Practices provide a framework 
and benchmark of leading pharmaceutical waste management practices that can 
guide Dr,. Reddy’s Laboratories’ leadership into integrating their waste management 
practices into their plans of setting up a manufacturing plant in South Africa. 
This section of the research comprises of sub-sections that provides a background to 
Dr. Reddy’s Laboratories in India and its waste management practices.  A detailed 
overview is given to outline each component of Dr. Reddy’s waste management 
strategy.  A further sub-section describes as per the literature review, waste 
definition, types of waste, waste management, waste management strategy 
implementation and management processes.  Also contained within this section of 
the research are the results of the survey that was conducted at Dr. Reddy’s 
Laboratories in India.  The survey was conducted through the utilisation of a 
questionnaire directed at both factory employees and middle managers who are 
involved with waste management practices at Dr Reddy’s manufacturing facilities in 
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Hyderabad, India.  The questionnaire was compiled using criteria for waste 
management as outlined in Pharmaceutical Good Manufacturing Practices, 
Internationally accepted Waste Management Guidelines as well as criteria outlined in 
South African and Indian Waste Legislation.  Survey participants were requested to 
rate Dr. Reddy’s in terms of compliance to the identified criteria and make 
recommendations that they believed if implemented would improve overall waste 
management at the company. 
1.2 Literature Review 
The objective of the literature review is to provide a critical assessment and 
evaluation of previous research in the field of waste management in general as prior 
research was done mostly in other industries and not to a large scale in the 
pharmaceutical industry.  The literature review evaluates the key elements of an 
effective waste management strategy implementation and is followed by a review of 
literature pertaining to the description of pharmaceutical waste. 
The definition of waste in this study is largely based on the definitions given in the 
South African White Paper on Integrated Pollution and Waste Management (2000) 
which emphasises waste as “any unwanted substance that needs to be discarded”. 
The literature survey identified various requirements that need to be met in order to 
develop and implement successful waste management policies and practices in the 
pharmaceutical industry; these include storage, minimization, recycling,   and 
disposal of pharmaceutical waste. Collection of pharmaceutical waste was however 
not addressed in the literature reviewed. 
The Waste Management Hierarchy was identified in the literature reviewed as the 
preferred method to manage waste as it favours the minimisation of waste from the 
point of generation versus the traditional method of waste management which 
advocates dealing with waste at the end of pipe, usually by disposal to landfill. The 
Waste Management Hierarchy also favours the re-use and recovery of waste 
material through recycling, composting of waste energy facilities and only considers 
landfill as the last resort. However, critics of waste management were also identified 
in the literature, some of the critics include McDougall and Hruska (2000) who argue 
that the waste management hierarchy is of limited use as there is no scientific basis 
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for the way the hierarchy orders waste management treatment options in the way 
that it does. The criticism of the waste management hierarchy was also pointed out 
by Rasmussen, Vigso, Ackerman, Porter, Pearce, Dijkgraaf, and Vollengergh (2000) 
who believe that the waste hierarchy to be a generalised and flexible guideline form 
of formulating waste policies. 
The North Dakota Pharmaceutical Waste Guidance (2010) provides strict guidelines 
which should be followed in the handling of pharmaceutical waste. The guidelines 
amongst other things suggest strict labelling of waste containers with hazardous 
waste and storage of such containers in safe dedicated spaces, the guidelines also 
advocate that such stored hazardous must be subject to on-going weekly inspections 
by a suitably qualified waste inspector. Literature review of both Indian and South 
African legislation also revealed strict controls with regards to the storage of 
pharmaceutical waste. 
With regards to Waste Minimisation, the U.S. Environmental Protection Agency 
(1991) defines the requirements of Waste Minimisation in the Pharmaceutical 
Industry. The report states that source reduction of waste can be achieved through 
changes in products, raw materials, process technologies, or procedural and 
organisational practices, amongst a list of other things that can be done to minimise 
waste. 
Waste recycling refers to treating waste that is no longer useable in in its present 
form and using it to produce new products.  Rushton (2003: 186) lists the following 
as advantages of recycling: 
 conservation of resources 
 supply of raw materials to industry 
 reduction of waste disposed to landfill and incineration 
However, Rushton (2013) also mentioned critics of waste recycling, this will be 
mentioned in detail at a later section in this study. 
Challenges to managing pharmaceutical waste were also identified.  A condensed 
view of these four performance areas viz storage, minimization, recycling, and 
disposal of waste involves the definition and identification of different methods for 
Pharmaceutical Waste Disposal as described by Visvanathan (1996) who states that 
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hazardous waste disposal methods are available and all necessitate proper pre-
treatment, which is carried out with the objective of volume reduction and 
concentration of wastes, so that waste will be easily disposed of or stored without 
creating any detrimental effects to the environment; Dijkgraaf and Vollenbergh 
(2003) state that landfilling is a better option of disposal of hazardous wastes as 
private costs for incineration are much higher; and Blenkharn (2005) who advises a 
move away from costly destruction of clinical wastes by incineration; through waste 
minimization and additional segregation of wastes at source to reduce to a minimum 
that component of clinical wastes that carries a clear and unquestionable infection 
risk. 
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1.3 Research Method 
This is evaluation research in the form of a case study and the data collection 
method employed is the conduction of a survey through questionnaires.  The design 
and content of the qualitative research questions will be informed by methods of 
management and disposal of pharmaceutical waste from international best practices, 
and the template would be designed by the researcher and the major components of 
the questionnaire would be those identified by the Department of Environmental 
Affairs and Development Planning (2007). 
The research method also includes a document analysis of Dr. Reddy’s 2012 annual 
reports, Dr. Reddy’s 2010 Sustainability Report as well as reports compiled by the 
organisation’s Corporate Communications Division against Waste Management 
practices identified through literature review. 
1.4 Results 
The results are divided into two sections namely results from Dr. Reddy’s document 
analysis and results from the survey conducted at the Dr. Reddy’s Manufacturing 
facilities in India. 
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1.5 Dr. Reddy’s Waste Management Strategy 
Dr. Reddy’s Senior Management is fully committed to a zero waste generation 
strategy.  The organisation has consciously worked on reducing its carbon footprint 
for more than a decade now.  Management continually seek new and innovative 
ways of minimising its impact on the environment.  These efforts have resulted in 
declining consumption of finite resources and the use of infinite resources (fresh 
water and sustainable energy), zero discharge of harmful effluents and responsible 
disposal of hazardous waste.  Dr. Reddy’s strategic business partners (third party 
manufacturers) are also subject to high environmental, safety and quality standards 
(Dr. Reddy’s Laboratories, 2010) 
Dr. Reddy’s Waste Management Strategy includes the use of resin-based 
technologies as one innovative way that the organisation has used to reduce solvent 
usage, solid waste generation and effluent generation.  The organisation has made 
headway in the development of alternate catalysts to replace toxic and unsafe 
catalysts, thereby improving reaction efficiency and minimising effluent generation 
(Dr. Reddy’s Laboratories, 2010). 
1.5.1  Dr Reddy’s Waste Management Strategy Implementation 
1.5.1.1 Waste Minimisation 
Dr. Reddy’s quest is to become a ‘lean’ drug manufacturer.  To this end the 
organisation’s two-step strategy has been to drive down the generation of waste 
during the manufacturing process and then to dispose of waste efficiently.  In order 
to effectively implement both strategies and to achieve significant load-reduction, the 
company has formed waste minimisation teams at its manufacturing units 
(Dr. Reddy’s Laboratories, 2010).  Figure 1 below shows that during the 2009-10 
financial year, the total quantity of hazardous waste disposed of was 13,045 tons, a 
significant reduction of 37% over 2008-09.  This decline was on account of a large 
proportion of hazardous waste being up cycled to cement companies as alternative 
fuel. 
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Hazardous Waste Tons 
 
 
Figure 1: Reduction of Hazardous Waste generated at Dr Reddy's Manufacturing Facilities 
from 2006 -2010, adapted from Dr Reddy's 2010 Sustainability  
Another method that is in use at Dr. Reddy’s to minimise generation of waste has 
been minimising the consumption of solvents, with the remainder produced from the 
use of reagents and raw materials.  High toxicity, low flash points and high vapour 
pressure in air lead to many of the adverse effects of solvents on environment as 
well as on human health (Dr. Reddy’s Laboratories, 2010). 
Dr. Reddy’s Sustainability Report, 2010 further mentions that solvents are among the 
biggest concerns in the pharmaceutical industry and as a result their safe and 
responsible disposal is Dr. Reddy’s foremost priority.  The company’s primary aim is 
to minimise the use of solvents through the adoption of green chemistry, a 
philosophy and study of the design of products or substances that will not involve 
materials harmful to the environment.  The ideal scenario is to virtually stop pollution 
before it can even begin through the use of non-pollutants and to maximise their 
reuse through recovery systems. 
Dr. Reddy’s has substantially reduced use of Class I and Class II solvents.  
According to Dr. Reddy’s 2010 Sustainability Report, Class I solvents include 
solvents with known human carcinogens, strongly suspected human carcinogens, 
and those that pose environmental hazards.  Class II solvents on the other hand 
have non-genotoxic animal carcinogens or possible causative agents of other 
irreversible toxicity such as neurotoxicity or teratogenicity.  Dr. Reddy’s is particular 
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that any solvents used in its manufacturing processes are benzene free (Dr. Reddy’s 
Laboratories, 2010). 
In one of Dr. Reddy’s plants, solvent was procured in barrels and then decanted for 
usage.  This not only led to wastage of solvents through evaporation but also 
exposed lab personnel to harmful solvent vapours.  This situation was proving to be 
financially expensive, hazardous to personnel health and exposing business to 
safety and regulatory risks.  Dr. Reddy’s intervened by developing an innovative 
closed-looped mechanised solvent handling system.  In this system, the solvent is 
pumped from a tank via a pipe to the product.  This process is quick and easy and 
offers leak free transfer of solvents (Dr. Reddy’s Laboratories, 2010). 
Not only has Dr. Reddy’s managed to minimise the use of solvents as a means 
towards waste reduction, but wastage of solvent and transfer losses have been 
virtually eliminated.  Environment and personnel hazards during solvent handling 
have also been eliminated.  Usage of barrels has been reduced and along with it the 
resources needed to treat and clean them before disposal have also been reduced 
significantly (Dr. Reddy’s Laboratories, 2010). 
1.5.1.2 Waste Storage at Dr. Reddy’s 
Waste at Dr. Reddy’s is segregated into different categories and these are then 
treated and stored in different ways as per the Standard Operation Procedure (SOP), 
relevant SOPs exist for each waste category, (see Appendix B for details of how the 
different categories are stored), the categories are as follows: 
a) Recipient, Treatment & Storage of Hazardous Waste Date Expired, Discarded 
Off Specification Drugs & Medicines (Hazardous Waste Category-28.3, 28.4) 
b) Residues and Waste (Hazardous Waste Category-28.1) 
c) Spent Organic Solvent (Hazardous Waste Category-28.5) 
d) HDPE Chemical Containers and Liners (Hazardous Waste Category-33.3) 
e) Effluent Treatment Plant Sludge (Hazardous Waste Category 34.3) 
f) Waste/Used Oil (Hazardous Waste Category-5.1) 
g) Other Hazardous Waste 
h) Bio-Medical Waste 
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1.5.1.3 Recycling and Re-use  
Recycling and Re-use at Dr. Reddy’s include wastewater recycling and solvent 
recovery.  The biggest challenge Dr. Reddy’s manufacturing plant had to face was 
the availability of good quality water in Hyderabad, particularly during the summer 
months.  A solution was found with the commissioning of a state-of-the-art 425KLD 
waste water recycling facility and commissioning of rain water harvesting.  It is 
expected to improve the water table considerably at the FTO 3 plant and at 
Bachupally, Hyderabad.  The good news is that already about 20 percent reductions 
in ground water TDS levels have been achieved over the last one year at FTO 3.  
Other systems implemented included a solvent recovery plant (SRS) for recovering 
solvents from process exhausts, acoustic enclosures for all the compressors, 
blowers and major energy conservation projects (Dr. Reddy’s Laboratories, 2012). 
1.5.1.4 Waste Disposal  
The API (Active Pharmaceutical Ingredients) manufacturing process generates high 
calorific value organic residue, mostly from the solvent distillation process.  These 
wastes were earlier disposed either through site incineration or sent to TSDF for 
incineration.  The opportunity of consumption of high calorific value wastes such as 
sludge from petrochemical plant; spent solvent residue from pesticide plant in 
cement industry as alternate fuel was thereby explored (Dr. Reddy’s, 2010). 
The waste generated at the Dr. Reddy's API plants had a calorific value equivalent to 
the other waste already used in cement kiln; hence an effort was initiated to look at 
the possibilities of utilisation as alternate fuel, by co-processing waste residue 
material as a source of energy, to minimise use of fossil fuels at cement plants 
(Dr. Reddy’s Laboratories, 2010). 
Although there were some restrictions and uncertainties in types and quantities of 
wastes that could be used as fuels in cement plants, this form of disposal was found 
to be cost effective, with less environmental impact as compared to conventional 
disposal methods such as land fill and incineration (Dr. Reddy’s Laboratories, 2010). 
With regards to Hazardous Waste, Dr. Reddy’s has Standard Operating Procedure 
for the disposal of Hazardous waste which amongst other things states the following: 
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 That detoxified drums & liners be handed over to scrap yard for disposal. 
 Waste/Used Oil shall be disposed to authorised recyclers through and 
agreement. 
 Waste/Used batteries shall be handed over to manufacturer/dealer on buy 
back policy or disposed to CPCB (Central Pollution Control Board) approved 
recyclers with an agreement as per the Batteries Management & Handling 
Rules, 2001 of Government of India. 
 Bio-Medical Waste shall be disposed periodically to APPCB approved facility 
as per Biomedical Waste Management & Handling rules, 1998 of Government 
of India along with manifest copy through an agreement. 
1.5.1.5 Conclusion  
Upon reflection of Dr. Reddy’s waste management practices and strategy, it is 
evident that Dr. Reddy’s has a waste management plan and procedures in place.  
The waste management processes followed at Dr. Reddy’s conform to the 
processes and legislation defined in the literature review.  What is however not 
evident in all company documents and websites that were reviewed is how the waste 
management strategy is filtered down and correctly implemented by the 
organisation’s employees, this however does not imply that the objectives of properly 
managing waste at Dr Reddy’s manufacturing facilities were not met, in reality the 
strategy was well managed and objectives successfully implemented but there is still 
room for improvement as was ascertained during the survey conducted amongst 
employees at the manufacturing plant in Hyderabad, India indicating that many do 
not fully understand waste management processes that are being implemented at 
the factory.  
1.6 Dr. Reddy’s Laboratories Survey Results 
This section presents the consolidated view of the survey conducted to identify 
Dr Reddy’s waste management practices and the understanding of such practices 
amongst employees.  The data was analysed and interpreted following the 
questionnaire structure, namely: 
- A potential reason from employees regarding the need for Dr. Reddy’s to 
have a Waste Management Strategy in place. 
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- Awareness of Current Waste Management Processes being implemented at 
Dr. Reddy’s. 
- Awareness of Indian Waste Legislation regulating the Pharmaceutical 
Industry. 
- The application of Waste Minimisation processes at Dr. Reddy’s. 
- Implementation of Recycling and Re-use processes at Dr. Reddy’s, 
- Level of understanding of Waste Management Practices amongst Dr. Reddy’s 
employees. 
- Areas of waste management improvement. 
- Employee recommendations on how to improve the level of the adoption of 
waste management practices by fellow employees at Dr. Reddy’s. 
1.6.1  Reasons from employees Why Dr. Reddy’s needs a Waste Management 
Strategy 
The respondents were asked to give their reasons as to why they deemed it 
important for Dr. Reddy’s to have a waste management strategy in place.  This is 
because literature reviewed indicated that employees need to understand the need 
for a waste strategy for them to buy into it. 
 
 
54% of respondents believe that the reason why Dr. Reddy’s needs to have a waste 
management strategy in place is to reduce environmental pollution and protect the 
environment, this is in line with the company’s commitment to protection of the 
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environment as stated in the organisation’s sustainability report.  It is however 
alarming that 28% of respondents do not seem to have a clear understanding as to 
why the company has a waste strategy in place; these respondents gave reasons 
ranging from enhancing organisational reputation to simply believing that there is a 
need for a waste management strategy without stating any apparent reason.  8% 
and 7% believe the reason Dr. Reddy’s has a waste management strategy is to be 
sustainable and to save on cost, respectively while 3% believe Dr. Reddy’s adopted 
a waste management strategy simply to comply with regulation, all these three 
reasons have been stated in literature reviewed as some of the benefits of having a 
waste management strategy in place for corporations. 
1.6.2 Awareness of current waste management processes being implemented 
at Dr. Reddy’s 
It is important for employees to be aware of current waste management processes 
being implemented in an organisation in order to adhere to policies and prevent 
generation of waste. 
 
26% of respondents claimed that they did not know what current waste management 
processes were being implemented, followed by 25% of respondents who indicated 
that they were aware of wastewater treatment and recycling processes at 
Dr. Reddy’s.  Only 18% claim to be aware of stringent Hazardous Waste 
Management processes at Dr Reddy’s despite the organisation showing a significant 
decrease in Hazardous Waste generation between 2006 and 2010 in its 2010 
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Sustainability Report.  Only 18% and 13% of respondents respectively are aware of 
efforts by the organisation to reduce, reuse and safely dispose of waste as well as of 
the treatment of effluent generated at Dr Reddy’s manufacturing plant. 
1.6.3 Awareness of Indian Legislation regulating the pharmaceutical industry 
Literature reviewed indicated the importance of legislation in regulating 
pharmaceutical waste. 
 
 
 
Results indicate that 30% of respondents do not know what waste legislation 
regulates the Indian pharmaceutical company with some respondents suggesting 
that no waste legislation exists as far as they are aware; some even going to the 
extent of suggesting that legislation exists only in paper and is not being adhered to 
in the pharmaceutical industry.  Of the other 70% of respondents, 15% are aware of 
the Resource Conservation and Recovery Act, 30% are aware of the Hazardous 
Waste (Management & Handling) Act (1989 and 2000), while 31% is aware of the 
Environment Protection Act of 1986. 
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1.6.4 Application of waste minimization processes at Dr Reddy’s 
It is vital for employees, both those involved with handling waste as well as general 
shop floor employees to be aware of waste minimisation processes in the 
organisation in order for them to be able to follow such processes in an effort to 
minimise the generation of waste in the manufacturing processes. 
 
 
 
From the results, it is indeed alarming that 46% of respondents do not know what 
waste minimisation processes are currently in place at Dr. Reddy’s.  36% of 
respondents believe that the implementation of new technologies and the use of 
automated fast equipment in the manufacturing processes has resulted in significant 
waste minimisation at Dr. Reddy’s, while 18% of respondents believe effluent 
treatment is practiced in order to minimise waste at Dr. Reddy’s.  It is evident from 
the high percentage of respondents that are not aware of waste minimisation 
processes at Dr. Reddy’s that communication regarding these processes should be 
communicated to employees and management must ensure that there is clarity at all 
levels of the organisation regarding such processes. 
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1.6.5 Implementation of Recycling and Re-use processes at Dr. Reddy’s 
 
 
 
Of those surveyed, 41% indicated their awareness of Wastewater Recycling 
processes at Dr. Reddy’s; this high percentage of respondents does not come as a 
surprise as Dr. Reddy’s has a dedicated waste water treatment plant.  23% of 
respondents are aware of solvent recovery; this figure should be higher as 
Dr Reddy’s documents indicate solvent recovery a priority for the company.  18% of 
respondents indicated that they do not know of any waste recycling processes at the 
company, whereas the other 18% do know of recycling processes but no recycling is 
done in their plants but recycling of waste from their particular plant is done by a third 
party.  Some of those respondents who were aware of wastewater recycling 
mentioned wastepaper recycling as a process currently in place at Dr. Reddy’s as 
well. 
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1.6.6 Level of understanding of Waste Management Practices amongst Dr. 
Reddy’s employees 
 
 
 
The objective was to have employees analyse their understanding of Waste 
Management Practices at Dr. Reddy’s.  Limited awareness of waste management 
practices means an individual respondent feels they are not aware of the existence 
of waste management practices at Dr. Reddy’s, let alone understand them, 36% of 
those surveyed said they were not aware of any waste management practices at 
Dr. Reddy’s.  13% of respondents indicated that they were aware of such practices 
but did not understand them; this could be due to language barrier as some of the 
workers are not first language English speakers.  44% of the respondents indicated 
that they have received clear and regular training and that the departments were well 
aware of waste management practices at Dr. Reddy’s and of those respondents 
none of them thought the training was casual and ad hoc, indicating that they 
regarded the training as formal and organised.  7% of respondents indicated that 
there is emerging awareness of the adoption of Waste Management Practices 
amongst employees at Dr. Reddy’s. 
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1.6.7 Areas of waste management improvement 
 
 
 
72% of respondents believe that Dr. Reddy’s has to improve its waste minimisation 
processes, this agrees with the earlier result which indicated that 46% of 
respondents did not know what minimisation processes were in place at Dr. Reddy’s, 
this indicates that employee training on waste management is needed.  Only 13% 
believe Dr. Reddy’s needs to improve on its waste recycling processes, this low 
percentage indicates that current waste recycling processes are performing well with 
only slight room for improvement.  Only 7% of respondents believe there is no need 
for Dr. Reddy’s to improve on any areas of its waste management and believe that 
the company is on par with other pharmaceutical companies in India.  2% and 3% of 
respondents believe that there is a need for Dr. Reddy’s to improve on its waste 
re-use and disposal, respectively. 
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1.6.8 Employee recommendations on how to improve the level of the adoption 
of waste management practices by fellow employees at Dr Reddy’s 
 
 
 
Of the employees surveyed, a significant 80% of respondents would like the 
company to establish departmental committees to oversee waste management 
projects, processes and operational issues.  13% would like to have ongoing staff 
training on waste management, 3% would like the company to conduct employee 
satisfaction survey to determine the level of satisfaction amongst employees on 
current waste management practices, while 4% of respondents believe nothing can 
be done to improve the level of waste management practices by fellow employees. 
1.7 Conclusion 
This case study while initially undertaken to assess waste management at 
Dr. Reddy’s laboratories has through the survey conducted, revealed gaps in the 
company’s waste management policy implementation created by failure to properly 
train and educate employees on waste management practices that exist at the 
organisation.  This can guide management’s thinking in forming a more intense 
communication and training strategy to ensure employee adherence to waste 
management policies and practices. 
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1.8 Discussion and Recommendations 
Results from the survey indicate that Dr Reddy’s need to improve certain aspect of 
its waste management practices as follows: 
1.8.1 Waste Management 
Company documents that were reviewed indicate that waste management policy 
exists at Dr. Reddy’s but has not been translated into effective procedures as 
indicated by the lack of awareness of waste management practices by a significant 
percentage of respondents.  This is despite the fact that most of those surveyed 
directly work with waste handling.  Another explanation could be that procedures 
exist but are not distributed to relevant parties.  Waste management policy at 
Dr Reddy’s is based on Indian legal requirements as it is evident in company 
documents that the company does strictly comply with Indian Waste Legislation.  
Results of the survey however, indicate that these legal requirements are not 
properly understood as 30% of employees that were surveyed had no idea what 
waste legislation regulates the pharmaceutical industry in India.  Not being aware of 
legislation and regulations can lead to non-compliance by employees, which has the 
potential of straining relations between the organisation and government and the 
likelihood of fines being imposed on the company for non-compliance. 
Rushton (2003) suggested that organisations develop a training programme for 
employees in an organisation in order to ensure that employees understand and 
comply with waste management policies and procedures.  A recommendation would 
be made therefore that Dr. Reddy’s develop a training programme for all relevant 
employees at the factory, this type of training should not only be directed at 
employees who are directly involved with waste handling but all company employees 
should be trained on the importance of waste management procedures to ensure 
that waste management is understood and filtered throughout the organisation.  To 
ensure that employees are constantly aware of waste management procedures and 
policies, management should communicate waste management successes to staff, 
senior managers, and stakeholders outside the organisation with an interest in waste 
management. 
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1.8.2 Waste Storage 
Dr. Reddy’s has Standard Operating Procedures with regard to waste storage.  
These Standard Operating Procedures is deeply entrenched in legislation that 
regulates the management of Hazardous waste in India.  Review of Indian and South 
African Waste Legislation has revealed a number of similarities between the two 
countries legislation pertaining to storage of waste, where very stringent regulations 
are in place for storage of hazardous waste.  However, South African Waste 
Legislation goes into much more detail than Indian Waste Legislation, with more 
regulations in place for storage of hazardous waste.  The recommendation would be 
that Dr. Reddy’s senior management should familiarise themselves with South 
African Waste Legislation prior to establishing a manufacturing plant in South Africa, 
the organisation would be required by law to obtain a licence from the South African 
Minister of Environmental Affairs and Tourism granting them permission to handle 
waste and would be required to submit a waste management plan before such a 
licence can be granted.  Various rules and regulations apply to waste storage in 
India and each is under the jurisdiction of specific authorities, the same applies in 
South Africa, which then means that Dr. Reddy’s would have to familiarise itself with 
the relevant authorities responsible for granting permission for the storage, handling 
and transportation of hazardous waste. 
1.8.3 Waste Minimisation 
From the results it is clear that Dr. Reddy’s is committed to waste minimisation 
through implementation of new technologies and the use of automated and improved 
equipment as indicated by 36% or respondents.  However, 46% of respondents were 
not aware of any minimisation processes that are in place.  Based on the research 
findings, the recommendation is that Dr. Reddy’s conduct a survey to determine the 
level of understanding of minimisation processes amongst its employees and 
address this through measures such as training and visible posters in work various 
work stations throughout the manufacturing plant, outlining in easy to understand 
language minimisation processes that need to be adhered to.  Management also 
needs to provide easy access to information and technical guidance to employees. 
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1.8.4 Waste Recycling and Re-use 
The findings indicate that there is a relatively good understanding of waste recycling 
processes amongst staff at Dr. Reddy’s, only 18% of respondents did not know of 
recycling practices at Dr. Reddy’s.  This could be those employees not directly 
involved with the handling of industrial pharmaceutical waste, but should however be 
aware of the importance of recycling, not only of waste but of recycling of other 
recyclable material such as waste paper recycling. 
1.8.5 Understanding of Waste Management amongst employees 
The findings suggest that Dr. Reddy’s does conduct regular and clear training to 
increase departmental awareness on waste management practices, but this training 
clearly has not succeeded in increasing levels of understanding on waste 
management practices among employees as there is still a high percentage of 
employees that do not understand or are aware of waste management practices at 
Dr. Reddy’s.  It is recommended therefore that Dr. Reddy’s ensure that each 
employee is evaluated after training to ensure common and proper understanding of 
what practices need to be followed if they are currently not doing this. 
1.8.6 Areas of waste management improvement 
The findings indicate recommendations from the employees at Dr. Reddy’s on what 
waste management practices need to be improved at the organisation.  72% of 
employees strongly believe that the company needs to improve on its waste 
minimisation processes; the recommendation is that management need to heed this 
call as it clearly shows that employees do not have an understanding of the 
company’s waste minimisation efforts, which carries the risk of non-compliance.  
Suggestions to address this include workshopping ideas with employees on waste 
minimisation processes they would like to see in place and measure the feasibility of 
such. 
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1.9 Case Study Conclusion 
The overall findings of this case study suggest that although management at 
Dr. Reddy’s are satisfied with waste management practices and results achieved at it 
manufacturing plant, there is however dissatisfaction amongst employees who 
believe the organisation has not successfully disseminated information and 
sufficiently trained them on waste management policies, processes and practices.  
There is therefore a desire amongst employees to be trained and to see the 
company improve on its waste management processes, this desire is a very 
important attribute as it indicates that employees at Dr. Reddy understand and are 
committed to the importance of waste management. 
On the legislation front, it is commendable that Dr. Reddy’s strive to adhere to Indian 
Waste legislation, however, literature reviewed does not indicate the existence of 
any stringent measures to ensure that non-compliance to legislation is punishable in 
India.  South African waste legislation seems to be more prudent in communicating 
clearly its punitive measures on non-compliance.  Dr Reddy’s would therefore need 
to engage a third party, preferably a legal expert to assist with the analysis of South 
Africa’s waste legislation versus Indian waste legislation to ensure clear 
understanding of local legislation prior to establishing a manufacturing facility in 
South Africa.  Areas of future research include determining in detail the financial 
benefits that a pharmaceutical company could gain by incorporating integrated waste 
management in its corporate strategy. 
 
 
 
 
 
 
 
31 
 
 
1.10 References 
BABBIE, E., 2008. The Basics of Social Reseach (4ed). Belmont, CA: Thompson 
Wordsworth. 
 
BERRY, M.A., RONDINELLI, D.A., 2000.  Environmental Management in the 
Pharmaceutical Industry: Integrating Corporate Responsibility and Business 
Strategy.  Environ. Qual. Mange.9:21-25 
 
BLENKHARN, J.I., 2005.  Safe Disposal and effective destruction of clinical wastes.  
18 South Road, Ealing, London W5 4RY, UK. 
 
DEAP, 2007. (Department of Environmental Affairs and Development Planning) 
Status Quo of Waste Management in the Consumer-Formulated Chemical Sector of 
the Western Cape. Pretoria: Department of Environmental Affairs and Development 
Planning. 
 
DJIKGRAAF, E., VOLLENBERGH, R.J., 2003. Burn or Bury?  A social Cost 
Comparison of Final Waste Disposal Methods.  Erasmus University, Rotterdam and 
OCFEB, Rotterdam. 
 
DR REDDY’S LABORATORIES, 2010.  Sustainability Report 2010 [Online].  
Available: http://www.drreddys.com/aboutus/sustainability.html.  [Accessed: 30 May 
2012]. 
 
DR REDDY’S LABORATORIES, 2010.  Molecules Memories and Moments: A 
Dr Reddy’s Presentation, July 2010.Dr Reddy’s Corporate Communications, 
Hyderabad, India. 
32 
 
DR REDDY’S LABORATORIES, 2012.  Annual Report 2012 [Online].  Available: 
http://www.drreddys.com/investors/pdf/annual [Accessed: 18 June 2012]. 
 
GUBA, E.G., LINCOLN, Y.S., 1994.  Competing Paradigms in Qualitative Research.  
In Denzin, N.K. and Lincoln, Y.S. (5ed).  Handbook of Qualitative Research.   
 
MC DOUGALL, F.R., HRUSKA, J.P., 2000.  “Report: the use of life cycle inventory 
tools to support an integrated approach to Solid Waste Management”.  Waste 
Management Res, 18:590-594. 
 
NGWULUKA, N.C., OCHEKPE, N.A., ODUMOSU, P.O., 2011.  An assessment of 
pharmaceutical waste management in some Nigerian Pharmaceutical Industries.  
African Journal of Biotechnology, 10, 54: 11259-11268, 19 September, 2011. 
 
North Dakota’s Pharmaceutical Waste Guidance 2010 [Online]. Available: 
http://www.ndhealth.gov/wm/Publications/NorthDakotaPharmaceuticalWasteGuidanc
e.pdf [Accessed: 19 June 2012] 
 
ORLIWOSKI, W.J., BAROUDI, J., 1991. Studying information technology in 
organizations: Research Approaches and Assumptions. Information Systems 
Research, 2,1: 1-28. 
 
RASMUSSEN, C., VIGSO, D., ACKERMAN, F., PORTER, R., PEARCE, D., 
DIJKGRAAF, E., VOLLENGERGH, H., 2005.  Rethinking the Waste Management 
Hierarchy.  Environmental Assessment Institute, Copenhagen. 
 
 
REMENYI, D., WILLIAMS, B., 1996. “Some aspects of ethics and research into the 
Silicon Brain.”, International Journal of Information Management,16,6: 401-411. 
33 
 
 
RUSHTON, L., 2003.  Health hazards and waste management.  British Medical 
Bulletin, 68:183-187. 
 
SEADON, J.K., 2010.  Integrated Waste Management, Doctor of Philosophy Thesis, 
The University of Auckland, and Auckland, New Zealand. 
 
VISVANATHAN, C., 1996.  Hazardous Waste Disposal.  Environmental Engineering 
Program.  Asian Institute of Technology. Bangkok, Thailand. 
 
WEYBRECHT, G, 2010, The Sustainable MBA: The Managers Guide to Green 
Business, West Sussex, England: John Wiley & Sons Ltd. 
34 
 
 
2 Section 2: Literature Review 
 
 
 
 
The section introduces the research area, provides the objectives of the research, 
provides contextual background information and describes the rationale for 
conducting the research.  This section further describes Dr. Reddy’s waste 
management practice as outlined in relevant company documentation and presents 
the results of the survey conducted amongst Dr. Reddy’s employees. 
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2.1 Introduction 
One system that an organisation should adopt to minimise the impact of its activities 
on the environment is that of waste management.  In order to establish and 
implement successful waste management policies, it is imperative to understand 
what constitute waste.  Defining material as “waste” has an impact on what 
measures can be taken with it, and also what restrictions on its transport, sale and 
reuse can be applied.  According to the European Council’s Directive on Waste, 
waste is “any substance or object which the holder discards or is required to discard” 
(Staniskis, 2005: 40).  This definition of waste may become a barrier to an efficient 
and sustainable management system.  “Sustainable waste management calls for 
resource conservation measures, which in turn requires that attention is given to 
more than just existing waste.  Waste management should entail control of 
processes that generate waste, waste handling, and waste utilization.”  (Staniskis, 
2005: 45). 
The objective of this literature review is to provide a critical assessment and 
evaluation of previous research in the field of waste management.  This literature 
review evaluates the key elements of an effective waste management process and 
implementation and is followed by a review of literature pertaining to pharmaceutical 
waste management and legislation pertaining to pharmaceutical waste. 
In the context of the aforementioned the research case study is to establish the 
implementation and success of waste management practices and policies at 
Dr. Reddy’s Laboratories.  The research is intended to address and highlight any 
issues with regards to waste management that need to be improved at Dr. Reddy’s 
manufacturing facilities in Hyderabad, India before the organisation could expand its 
manufacturing facilities to South Africa. 
2.2 Literature Review- Waste Management 
2.2.1 Introduction 
According to Envirowise, a government funded programme that offers free and 
valuable environmental advice to businesses in the UK, “The true cost of waste is 
not simply the cost of discarded materials - it encompasses inefficient use of raw 
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materials, unnecessary use of energy and water, faulty products, waste disposal of 
by-products, waste treatment and waste labour.  The actual cost of such waste for 
UK companies is typically 4-5% of turnover, and can be as high as 10%.”  Effective 
management of waste should therefore be part of every organisation’s 
Environmental Management System.  Waste management does not only allow 
organisations to minimise the impact of their activities on the environment but it also 
allows them to reduce costs by making processes more efficient and by minimising 
or eliminating waste.  This chapter provides an introduction to the key concepts 
required for waste management.  The chapter further explores the foundational 
attributes of the pharmaceutical waste management process required for effective 
waste management. 
2.2.2 Definition of Waste 
In the South African White Paper on Integrated Pollution and Waste Management 
(2000), waste is defined as: “[An] undesirable or superfluous by-product, emission, 
or residue of any process or activity which has been discarded, accumulated or been 
stored for the purpose of discharging or processing.  It may be gaseous, liquid or 
solid or any combination thereof and may originate from a residential, commercial or 
industrial area.  This definition includes industrial wastewater, sewage, radioactive 
substances, mining, metallurgical and power generation waste.” 
The White Paper on Integrated Pollution and Waste Management (2000) further 
argues that there is ongoing debate as to the exact definition of waste as a result of 
an increasing global trend to reduce, re-use, rework, recycle, recover, what is termed 
“waste” products.  This is further complicated by the fact that one man’s waste can 
be another man’s valuable raw material.  A general definition of waste could 
therefore be redefined as “something that nobody wants at a particular moment in 
time and that needs to be disposed of”.  Waste can be classified into hazardous 
waste, a broad term for a wide range of substances that may have variable degrees 
of risk.  This includes for instance, toxic substances that may cause cancer.  The 
three largest waste streams in the hazardous waste category are oils and oily 
wastes, construction and demolition waste and asbestos, and waste from organic 
chemical processes.  Other types of waste which do not pose the same level of risk, 
such as certain types of household waste are classified as non-hazardous waste. 
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2.2.3 Definition of Waste Management 
Waste management refers to the collection, transport, processing, disposal, 
managing and monitoring of waste materials.  Waste management usually relates to 
materials produced by human activity, and the process is generally undertaken to 
reduce their effect mainly on health and the environment.  Waste materials can be 
solid, liquid, gaseous or radioactive and all these different forms fall within the realm 
of waste management.  The priority in which wastes should be managed is 
demonstrated below in the waste hierarchy (Figure1) as promoted in most 
international companies’ waste management strategies. 
 
 
 
  
 
Waste management hierarchy 
  
Cleaner production 
Avoidance 
Minimisation and reduction 
  
Recycling and processing 
Re-use 
Recovery 
Composting 
Treatment Physical 
Chemical 
Destruction 
Disposal Landfill 
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Figure 2: The waste management hierarchy requires moving waste management from disposal 
to landfill to preferred options higher in the hierarchy 
The hierarchy stresses the need to firstly reduce the amount of waste created, then 
re-use the wastes, then recover (via recycling, composting or waste-to-energy 
facilities) and finally, as a last resort to dispose the waste to landfill.  Whereas the 
traditional method of waste management deals with waste at the end of the pipe, 
once it is produced, usually by disposal to landfill, waste hierarchy on the other hand 
maintains that the most successful means to manage waste is not to produce it in 
the first place and this is the driving force behind the idea of waste minimisation. 
Critics of the waste hierarchy believe it is not the best form of waste management, 
McDougall and Hruska (2000) argue that there is increasing awareness that the 
waste management hierarchy which ranks treatment options in a descending order 
of desirability, is of limited use.  The authors argue that no scientific basis exists for 
ordering waste management treatment options in this way.  McDougall and Hruska 
(2000) believe that the hierarchy cannot provide any guidance with respect to using 
combinations of treatment technologies.  They further believe that the waste 
management hierarchy does not, and cannot, address cost issues and will not 
identify the best practical environmental option with respect to planning waste 
management systems. 
This criticism of the waste hierarchy is shared by Rasmussen, Vigso, Ackerman, 
Porter, Pearce, Dijkgraaf, and Vollengergh (2005) who argue that the waste 
hierarchy must be considered a very generalised and flexible guideline form of 
formulating waste policies.  The authors emphasise that what is environmentally 
desirable is not always the solution when viewed from a socio-economic perspective 
and that some environmental benefits may come at a comparably socially high cost.  
Rasmussen et al. (2005) further share the opinion that marginal costs and benefits 
will vary depending on material and locality.  Their recommendation is that social 
costs and benefits of new recycled schemes be analysed first and a critical 
assessment be made to determine if further steps are in fact socially desirable. 
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2.2.4 Waste Avoidance/Minimisation 
Waste avoidance refers to the prevention of waste generation or the reduction of 
generated wastes.  According to the Gwydir Shire Council - Waste Management 
Plan 2012, examples of practices for achieving waste avoidance include: 
 input substitution 
 increased efficiency in the use of raw materials, energy, water or land 
 process redesign 
 product redesign 
 improved maintenance and operation of equipment 
 closed-loop recycling 
The UK based Chartered Institute of Purchasing and Supply believes that for any 
organisation to take action to reduce waste, it must take its high level plan and turn it 
into an action plan, this requires the organisation to start by identifying obvious areas 
of waste reduction where immediate and substantial savings can be achieved by 
implementing no-cost and low-cost measures.  A Waste Minimisation Assessment 
Procedure as shown below should be adopted by every organisation: 
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                 The Recognized Need to Minimise Waste 
 
 
 
 
  
 
 
 
                        
                            
                                             
                
 
 
 
 
 
 
                            
                           
        
 
 
                                          
                                                 
 
 
 Planning and Organization Phase 
 Get management commitment 
 Set overall assessment program goals 
 Organize assessment program task force 
Assessment Phase 
 Collect process and site data 
 Prioritize and select assessment targets 
 Select people for assessment teams 
 Review data and inspect site 
 Generate options 
 Screen and select options to further study 
Feasibility Analysis Phase 
 Technical evaluation 
 Economic evaluation 
 Select options for implementation 
     
Assessment Organisation & Commitment to proceed 
Assessment Report of selected options 
 
Figure 3 The Waste Minimisation Assessment Procedure, Adapted from the U.S. 
Environmental Protection Agency. 
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According to the Chartered Institution of Waste Management and The Waste 
Framework Directive of 1991 (91/156/EEC), there can be a distinction between: 
i) Qualitative waste prevention and reduction 
It includes the use of less toxic or hazardous resources and the production of less 
toxic or hazardous wastes.  This is particularly interesting for the chemical 
industry as several of the reactant substances are hazardous and often toxic and 
their substitution might have an effect on the qualities of the product. 
ii) Quantitative waste prevention and reduction 
It includes the use of less resources and the production of less waste in terms of 
waste per unit of products.  That is, it sets as a target the maximum possible 
minimization of waste per product used.  (Kefala and Romano, 2006: 14) 
Companies that seek to improve their environmental performance can do so by 
either using control or clean technologies (Murphy and Gouldson, 2000: 36).  The 
former are end-of-pipe technologies that are used to treat any waste after it has been 
produced.  Cleaner production according to Zhi-dong, Zhang, Zhang, Zhang, and 
Wei (2011: 195) is an effective way to reduce waste emission and save resources, 
and has been widely employed in the pharmaceutical industry in developed 
countries.  According to the U.S. Environmental Protection Agency Report (1991) 
waste minimisation in the pharmaceutical industry involves the following: 
 Source reduction of hazardous waste which can be achieved through 
changes in products, raw materials, process technologies, or procedural and 
organisational practices. 
 Material substitution in the form of a change in one or more of the raw 
material used in production in order to reduce the volume of toxicity of waste 
generated. 
 Process modification by looking for source reduction opportunities that can be 
accomplished through modification or modernisation of the existing process, 
for example, automated systems for material handling and transfer, such as 
conveyor belts for bagged materials, can help reduce spillage. 
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Waste reduction is the key to reducing the growing waste mountain, and thus 
the key to sustainable waste management.  Reducing the thickness of plastic 
bags is a method of reducing waste quantities by reduction in the amount of 
packaging (Williams, 2005) 
2.2.5 Waste Re-use 
If waste cannot be reduced then waste re-use is the next priority.  Re-use can be 
defined as “using a product or package more than once or re-using it in another 
application” (Williams, 2005: 129). 
The Gwydir Shire Council – Waste Management plan 2012 describes Waste re-use 
as re-using waste, without first substantially changing its form.  Examples of waste 
re-use are: 
 recovering solvents, metals, oil, or components or contaminants from 
catalysts and re-using them for a secondary purpose 
 applying waste to land in a way that gives agricultural and ecological benefits 
 substituting waste for virgin material in a production process 
2.2.6 Waste Recycling 
Waste recycling refers to treating waste that is no longer useable in in its present 
form and using it to produce new products.  Rushton (2003: 186) lists the following 
as advantages of recycling: 
 conservation of resources 
 supply of raw materials to industry 
 reduction of waste disposed to landfill and incineration 
Composting is another form of waste recycling; this is an aerobic, biological 
process of degradation of biodegradable organic matter.  Rushton (2003) argues 
that composting has the advantage of reducing waste to dispose to landfill and 
incineration and that composting leads to recovery of useful organic matter for 
use of as soil amendment.  However, Rushton (2003) also criticizes composting 
by pointing the following of its disadvantages: 
 Composting leads to the production of Bio-aerosols which is organic dust 
containing bacterial and fungal spores which may be harmful to humans. 
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 Composting emits volatile organic compounds. 
 Composting is a potential pathway for contaminants to enter the food 
chain. 
 Composting is associated with bad odours, noise, and vermin nuisance. 
Critics of waste recycling argue that recycling has a number of disadvantages; this 
view is supported by Rushton (2003: 13) who states the following as disadvantages 
of waste recycling: 
 diverse range of processes 
 emissions from recycling process 
 may be more energy used for processes than original manufacture 
 currently low demand for products 
 requires co-operation from individuals 
2.2.7  Waste Treatment and Disposal 
Rushton (2003) has identified incineration and landfilling as two methods of waste 
treatment and disposal.  Incineration as a method of waste treatment is defined as a 
process of combustion designed to recover energy and reduce the volume of waste 
going to disposal.  Rushton (2003: 184) defines landfill as “ the deposition of waste in 
a specially designated area, which in modern sites consists of a pre-constructed ‘cell’ 
lined with an impermeable layer (man-made or natural) with controls to minimize 
emissions.” 
Advantages of incineration as a method of waste treatment have been identified by 
Dijkgraaf and Herman (2003: 2) as the following: 
 Incineration waste to energy facilities not only reduce final disposal of waste, 
but also produce electricity and/or heat, saving (energy) resources elsewhere. 
 Burning waste in waste incineration plants facilitates compliance with the 
Kyoto Protocol. 
However, Dijkgraaf and Herman (2003: 2) also identified disadvantages associated 
with incineration as the following: 
 Incineration plants also contribute to externalities such as emission to air and 
chemical waste residues. 
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 Incineration plants are expensive to build compared to even modern landfills. 
Taiwo (2011:95) also pointed out the following two disadvantages of incineration: 
construction and start-up costs of facilities, which could be too expensive for 
developing countries, as well as acid gases production. 
Landfilling as a form of waste disposal has been shown in literature review as still the 
dominating method of waste disposal.  Rushton (2003: 184) listed the following 
amongst advantages of landfilling: 
 cheap disposal method 
 waste used to back fill quarries before reclamation 
 landfill gas contributes to renewable energy supply 
 Dijkgraaf and Herman (2003: 2) concurred with these advantages but not only 
identified advantages of landfilling but also criticised this method of waste disposal 
by pointing out the following disadvantages associated with the method: 
 methane production, however Dijkgraaf and Herman(2003) further argue that 
methane can be a source of energy. 
 most landfills do not recover energy. 
 odour, dust , road traffic problems 
 leaking is often a serious problem, especially for older landfill sites. 
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2.2.8 Conclusion 
In review of the aforementioned waste management processes it can be noted that 
waste management is an important phenomenon that enables an organisation to be 
sustainable and reduce the impact of its activities on the environment and on human 
health.  This view is supported by Kefala and Romano (2004: 16) by stating that 
there have been several positive and encouraging results observed of business that 
have had financial benefits as a consequence of the introduction of a “‘greener 
policy’. 
Within them, businesses have created sustainability development policies and waste 
management is one of them.  As others have argued (Bebbington and Gray, 2001: 
560), at the moment there is a debate as to whether the business community could 
fulfil the sustainability requirements. 
2.3 Literature Review – Pharmaceutical Waste 
2.3.1 Introduction 
According to ToxicsWatch Alliance, an Indian based organisation that keeps track of 
callousness, corporate crimes, military-mining industrial complex and their impact on 
humans and ecosystem, “Pharmaceuticals form a group of substances that are of 
considerable importance for society as healthcare tools.  Given the fact that a variety 
of pharmaceuticals can now be detected in surface, ground, and drinking waters, 
there are valid concerns about the potentially adverse environmental consequences 
of this contamination.  The risk is directly proportional to the active concentration of 
the chemical substance in various environmental compartments, and pharmaceutical 
waste adds to that risk if not managed properly.”  (ToxicWatch Alliance against 
Pollution & Corporate Crimes, 2009: 1).  Naturally, there is growing concern that 
human health and aquatic life may be severely impacted as a result of exposure to 
pharmaceutical compounds. Key concepts covered in the literature reviewed include 
definition of waste (pharmaceutical hazardous waste in particular), waste 
management, waste storage, waste minimization, recycling, waste disposal as well 
as legislation pertaining to waste management. 
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2.3.2 Definition 
Pharmaceutical waste is defined according to ToxicWatch Alliance as “a 
pharmaceutical that is a hazardous waste.”  Sources of pharmaceutical waste 
include excreted substances, improper disposal by hospitals and patients, 
agricultural waste due to veterinary use and livestock feed additives (Zuccato et al., 
2000; Heberer, 2000, cited in Ngwuluka et al., 2011).  This research will only focus 
on pharmaceutical waste in the context of the pharmaceutical manufacturing 
industry. 
2.3.3 Hazardous waste 
The National Environmental Management: Waste 
Act 59 of 2008, (Waste Act) of South Africa defines Hazardous Waste as “any waste 
that contains organic or inorganic elements or compounds that may, owing to the 
inherent physical, chemical or toxicological characteristics of that waste, have a 
detrimental impact on health and the environment”.  Sharma, Dilip, Khilip, Gupta, 
and Bisht (2010: 333) give a more detailed definition of hazardous waste by defining 
a characteristic hazardous waste as a waste that has been identified to exhibit one 
or more of the following attributes: 
1. Ignitable: 
A. Flash point is less than 140 degrees Fahrenheit (e.g. solutions containing 
more than 24% alcohol). 
B. An oxidiser. 
C. An ignitable compressed gas as defined by the U.S. Department of 
Transportation (e.g. some aerosol propellants). 
2. Corrosive: 
A. The pH is less than or equal to 2.0 or greater than or equal to 12.5. 
B. It is a liquid and corrodes steel at a rate greater than six and thirty-five 
hundredths millimetres per year (e.g. compounding chemicals, including strong 
acids, such as glacial acetic acid, and strong bases, such as sodium 
hydroxide). 
3. Reactive: 
A. Reacts violently with water. 
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B. It is normally unstable and readily undergoes violent change without 
detonating. 
C. It forms potentially explosive mixtures with water. 
D. When mixed with water, it generates toxic gases, vapour or fumes in a quantity 
sufficient to present danger to human health. 
4. Toxic: Fails to the Toxicity Characteristic Leaching Procedure (TCLP) (e.g. 
contains arsenic, barium, cadmium, chloroform, chromium, lindane, m-cresol, 
mercury, selenium or silver at a concentration equal to or greater than the 
regulatory level). 
See fig.1 below for a summarised definition of classes of hazardous waste.  
 
 
Figure 4 Nine Hazardous Waste Classes, Adapted from DEDEA Environmental Plans - 
Hazardous Waste Management Plan. Overview of Hazardous Waste Treatment Options - Draft 
2009. 
48 
 
 
The table below further gives examples of waste generated per class: 
 
Table 1: Examples of Types of Waste per Waste Class 
2.3.4 Types of Pharmaceutical Waste 
According to the U.S. Environmental Protection Agency Guidelines to Pollution 
Prevention, the Pharmaceutical Industry (1991), “Pharmaceutical manufacturing 
plants generate a variety of wastes during manufacturing, maintenance and 
housekeeping operations.  Typical waste streams include spent fermentation broths, 
process liquors, solvents, equipment wash waters, spilled materials, off-spec 
products, and used processing aids”.  Pharmaceutical waste may be present in any 
of the common physical forms like solids, liquids and gases.  The waste can be 
categorized in several ways, e.g., depending on source, physical state, hazard, 
security, handling and disposal (ToxicWatch Alliance against Pollution & Corporate 
Crimes, 2009:2).  Andreassen and Fletcher (1993) identified three main sectors that 
contribute to the generation of waste in the pharmaceutical industry, these are: 
Research and Development where generally everything that enters a R&D site 
leaves as waste but the main form of waste produced is paper due to the 
considerable amount of paper used which includes drug registration documents, 
trials data, process details etc. 
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Primary manufacturing where there is considerable use of organic solvents in 
synthetic work and the vast use of water in fermentation processes.  The main 
sources of waste from a facility are liquids and solids, in that order. 
Secondary Manufacturing is probably the least wasteful of the three sectors.  
Andreassen and Fletcher (1993) identified water as the first waste from this sector 
and packaging material as another main waste from the secondary sector. 
Pharmaceutical waste includes expired, unused, spilt and contaminated 
pharmaceutical products, drugs, vaccines and discarded items as bottles, vials, 
connecting tubing (Samakhanova, 2006: 7). In the case of Dr Reddy’s, this study is 
more concerned with waste generated during the manufacturing process. 
Other types of pharmaceutical waste identified in literature review include 
halogenated/non-halogenated solvents, sludge & tars, heavy metals, organic 
chemical residues from still bottom, test animal remains, return pharmaceuticals, 
low-level radioactive waste, contaminated filters, etc. 
2.3.5 Pharmaceutical Waste Management 
Andreassen and Fletcher (1993) argue that the first necessary step to take after 
making a company commitment to improving waste management is to establish what 
the current situation is at the working level, the authors suggest that a waste audit be 
undertaken for this reason; such an audit is typically comprised of: 
 A review of the waste management structure 
 An inspection of the generation, handling and disposal of waste 
 An assessment of compliance with existing legislation 
 An assessment of the implications of forthcoming legislation. 
Andreassen and Fletcher (1993) suggest that result of such audits should be listed 
and discussed under the following sections: 
 Waste Management 
 Waste Storage 
 Waste Generation/Disposal 
 Waste Minimization 
This view of waste management is supported by Townsend and Cheeseman (2005, 
cited in Ngwuluka et al., 2011) , who propose that management of waste involves 
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waste segregation, waste collection, waste transportation, waste storage, waste 
disposal, waste minimization and reuse. I concur with  Ngwuluka et al (2011) who 
further mention that waste management requires the five pillars of management - 
planning organising, leading, co-ordinating and monitoring for efficacy and 
effectiveness. Incorporating the five pillars of management I believe is essential in 
ensuring that waste management is considered an important part of general 
management by senior management in any pharmaceutical company. 
2.3.6 Waste Management 
Andreassen and Fletcher (1993: 63) identified various scenarios that can exist with 
regards to waste management in the pharmaceutical industry, these are: 
 Policy statements exist, but have not been translated into effective 
procedures. 
 Procedures exist, but do not set out the requirements clearly or designate 
responsibility for actions. 
 A timetable for producing and implementing the procedures is non-existent or 
incomplete. 
 Procedures exist, but are not distributed. 
 Little or no training towards procedures is undertaken. 
 Procedures are based on legal requirements of other countries and are not 
directly applicable or understandable locally. 
Andreassen and Fletcher (1993) argue the importance of having work procedures 
relating to waste management in an organisation and of passing information on 
working methods in a written format as opposed to passing such information verbally 
to employees.  The authors also emphasise the importance of having a central figure 
responsible for waste management to ensure co-ordination of waste management 
activities throughout the organisation.  Both these views are supported by the U.S. 
Pharmaceutical Waste Management Guidelines which an organisation should 
appoint a Hazardous Waste Program Manager and/or Environmental Manager who 
shall: 
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 Develop a training program for all relevant personnel within the Environmental 
Programs Division, Pharmacy Department, and Nursing Department on 
handling and disposing of hazardous waste; 
 Develop an inspection program to ensure compliance with state and federal 
hazardous waste regulations; 
 Conduct a re-evaluation of the hazardous waste generator status of the 
activity based on the addition of hazardous pharmaceutical waste to the 
generated waste stream; 
 Develop new Standard Operating Procedures (SOPs) to ensure 
implementation of waste guidelines; 
 Integrate the new SOPs into the Environmental Management System (EMS); 
and 
 Modify other existing SOPs as necessary to implement the necessary 
guidelines. 
I agree with the above mentioned  which is also supported by the U.S. Chartered 
Institute of Purchasing and Supply (2007: 18) which listed top 10 Tips for managing 
wastes and developing waste strategies for companies, these are: 
1. Understand the legal implications of the waste produced in your organisation 
by identifying the specific legislation that affects you. 
2. Look at your general environmental issues - what role does your waste play in 
these? 
3. Quantify and identify your waste.  Where does it arise and how much does it 
cost?  Undertake a walk around audit and look at your bills.  Using the waste 
hierarchy, identify what currently happens to the waste as it arises. 
4. Identify a waste management champion or team to drive things forward. 
5. Produce an action plan for reducing your wastes. 
6. Get commitment from senior management for the action plan. 
7. Identify the possible disposal options where you cannot reduce or recycle. 
8. Select your waste carriers carefully and make sure your Duty of Care 
responsibilities are met. 
9. Monitor and review your achievements. 
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10. Communicate your successes to your staff, senior managers, and outside 
your organisation to interested stakeholders. 
Andreassen and Fletcher (1993) warn against the existence of a number of company 
sites with little coordination which may then lead to inconsistent approaches to waste 
management, where various standards and practices may arise.  This undesirable 
situation will then make it difficult to adopt common waste management procedures 
but can also provide an interesting selection of approaches from which the best can 
be chosen to form the basis of any new universal procedure. 
2.3.7 Waste Storage 
The North Dakota Pharmaceutical Waste Guidance provides general guidelines that 
should be followed in the handling of hazardous pharmaceutical waste.  The 
guidelines suggest that waste be separated and stored by waste classification, P- or 
U-listed, toxicity, ignitability, corrosivity or reactivity.  The North Dakota 
Pharmaceutical Waste Guidance (2010: 8) suggests that while containers of 
hazardous pharmaceutical waste are in storage: 
 Each container must be labelled “hazardous waste’. 
 Each container must be clearly marked with an “accumulation start date”.  The 
accumulation start date is the date that waste is first placed (accumulated) in 
the container. 
 Each container must be closed unless adding or removing waste. 
 The storage area must maintain adequate aisle space for inspections and 
emergency responses. 
 The containers in storage must be inspected weekly, and inspection log must 
be kept. 
The importance of proper waste storage is further emphasised by Andreassen and 
Fletcher (1993) who argue that uncovered, unsegregated, unbounded, unlocked 
storage areas for hazardous waste, as well as poor labelling of drummed waste are 
some of the improper waste management storage activities that do occur in 
pharmaceutical manufacturing plants.  Andreassen and Fletcher (1993: 63) further 
argue that “Adequate labelling of waste may only take place prior to transportation 
off –site.  Thus, in the event of an emergency situation or spillage on-site, personnel 
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may have little idea as to the nature of the contents and therefore of the optimal 
actions to be taken”.  Andreassen and Fletcher (1993: 63) therefore emphasise that 
“comprehensive labels, detailing the hazardous characteristics and constituents of 
the waste, should be placed on the waste containers as soon as possible”. In my 
opinion, labelling of waste containers may not entirely achieve the desired purpose in 
a factory like Dr Reddy’s where the majority of factory workers are illiterate. 
2.3.8 Waste Generation / Disposal 
The study conducted by Ngwuluka et al. (2011: 11261) looking at the assessment of 
pharmaceutical waste management in some Nigerian pharmaceutical industries 
revealed the following regarding the generation of pharmaceutical waste and 
wastewater: 
- Most of the respondents could not ascertain the quantity of waste generated.  Other 
respondents did not understand that it was necessary to know the quantity of waste 
generated as it would determine the method of disposal. 
- All manufacturing pharmaceutical industries generated wastewater, which resulted 
from the water used for process operations during manufacturing and in contact with 
intermediary, finished and/or by-products.  Wastewater could come from the water 
used to clean equipment, pipes and floors, and would contain amongst other 
materials, chemicals and active pharmaceutical ingredients. Ngwuluka et al. (2011: 
11262) also revealed how pharmaceutical waste is disposed of.  First, an industry 
would write stating the drugs or raw material to be disposed with quantities.  A staff 
member would go to assess the waste, container, the chemical content and the 
quantity, and a sample would then be taken for analysis to identify a suitable solvent 
that will dissolve the waste.  Ngwuluka et al. (2011: 11262) further explain that the 
identified solvent and pharmaceutical waste is mixed in a mixing tank, transferred 
into the diluting tank where pH is adjusted to neutral and diluted with water before 
the liquid is flushed into the environment. 
With regards to disposal of solid wastes generated during pharmaceutical 
manufacturing, Ngwuluka et al. (2011: 11263) identified open air burning as an 
unfavourable method of waste disposal as it generates toxic emissions into the air.  
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Pharmaceutical waste should be burnt in well-constructed incinerators at 
recommended temperatures with means of controlling emissions.  
According to Upadhyay et al. (2005: 264), landfill is the most common method for 
disposal of wastes in most countries.  As landfill is associated with continuous and 
long term operation, it is necessary to plan for effective solid waste management to 
achieve maximum reduction of wastes for disposal and landfill.  Upadhyay (2005) 
further argues that incineration is the commonly used process to reduce the quantum 
of solid wastes.  Incineration refers to the controlled burning of wastes at high 
temperature (500-1200 C) in a furnace especially designed for this purpose and the 
products of incineration are ashes and gases. I am more inclined to agree with 
Upadhyay et al (2005) who go on to criticise landfilling as a method of disposal as 
they argue that land availability , pollution of water and sail are some of the main 
problems faced in landfill disposal,  however, these problems can be minimized if the 
landfill area is scientifically designed, compacted and clay lined before dumping of 
wastes.  Upadhyay et al. (2005) suggest that the hazardous wastes could be treated 
properly through physical/chemical/biological methods before being dumped in 
landfill areas or disposed of in containers in the underground/ocean. 
Mathew and Unnikrishnan (2012) mention that industrial effluents in India are 
handled by end-of-pipe treatment, which like common effluent treatment plans, 
results in residual persistent organic pollutants and toxic metals in the treated water. 
2.3.9 Waste Minimisation 
According to Andreassen and Fletcher (1993: 66) once waste generation has been 
detailed, targets should be set for waste minimization.  ‘Target’ areas should be 
placed in a priority list where top of the list is areas where maximum reductions in 
waste generation can be obtained by the minimum degree of effort.  There are 
various means that the pharmaceutical industry can adopt to minimise waste 
including Green Chemistry, according to Mathew and Unnikrishnan (2012: 33) 
“Green chemistry minimises by-product waste and replaces the worst reactions with 
green technology.  Many routine chemical reactions in pharma manufacturing can be 
replaced with green but expensive alternatives.”  This view is supported by 
Sharma N et al. (2010: 333) who states that “the pharmaceutical industry has made 
progress over the past several years in practicing “green chemistry”, for example by 
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minimizing use of reagents that are hazardous to the environment and by designing 
alternate synthesis pathways”. 
Other measures to minimize waste in pharmaceutical manufacturing were identified 
by the U.S. Multilateral Investment Guarantee Agency and include the following: 
 Meter and control the quantities of active ingredients to minimise wastage. 
 Reuse by-products from the process as raw materials or as raw material 
substitutes in other processes. 
 Recover solvents used in the process by distillation or other methods. 
 Give preference to the use of non-halogenated solvents. 
 Use automated filling to minimize spillage. 
 Use “closed” feed systems into batch reactors. 
 Use equipment wash-down waters and other process waters (such as 
leakages and pump seals) as make-up solutions for subsequent batches. 
 Recirculate cooling water. 
 Use dedicated dust collectors to recycle recovered materials. 
 Vent equipment through vapour recovery systems. 
 Use loss free vacuum pumps. 
 Return toxic materials packaging to the supplier for reuse or 
incinerate/destroy in an environmentally acceptable manner. 
 Minimize storage time of off-specification products through regular 
reprocessing. 
 Find productive uses for off-specification products to avoid disposal problems 
 Minimize raw material and product inventory to avoid degradation and 
wastage. 
 Use high pressure hoses for equipment cleaning to reduce wastewater. 
 Provide storm water drainage and avoid its contamination from process areas. 
 Label and store toxic and hazardous materials in secure bounded areas. 
Spillage should be collected and re-used. 
2.3.10 Conclusion 
This section highlighted the scenario of waste management in the pharmaceutical 
manufacturing sector and the options available for the management, storage, 
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generation and disposal, as well as minimization of such waste.  The literature 
reviewed indicated that the Pharmaceutical Industry generates various kinds of 
wastes of biodegradable and non- biodegradable categories.  The impact of such 
waste on the environment is enormous, if not properly managed and disposed of.  
Some pharmaceutical waste can be recycled, such as solvents, and the industry 
can also minimise the generation of wastes and exercise proper collection and 
disposal technologies of waste that already exists. 
2.4 Literature Review – Waste Legislation 
2.4.1 Introduction 
Environmental legislation is a relatively young approach to waste and pollution 
control, with most environmental legislation having been passed in the past 20-30 
years in developed countries, and even more recently in developing countries 
(Goodstein,2002, cited in Godfrey and Nahman,2007).  Godfrey and Nahman (2007: 
1) argue that while regulatory controls have historically been the dominant approach 
to controlling pollution in developed and developing countries, a shift in governance 
away from ‘policing’ to one of co-operation has seen the introduction in developed 
countries of a number of ‘softer’ alternative, policy instruments.  In developing 
countries, regulatory control remains the principle means of waste and pollution 
control; however, failures in compliance and in the enforcement of waste legislation 
have generally resulted in deterioration in the management of waste (Sterner, 2003 
cited in Godfrey and Nahman, 2007).  Oelofse and Godfrey (2008: 245) mention the 
importance of the definition of waste to the regulation of waste and the control of 
possible negative impacts of waste on the environment and human health if not 
properly manages.  Oelofse and Godfrey (2008) thus conclude that waste should be 
defined in a way that will support the regulation of the environmental impacts and 
support the principles of integrated waste management as outlined in the waste 
hierarchy. 
2.4.2 Indian Waste Legislation 
The Indian pharmaceutical industry produces bulk drugs belonging to all major 
therapeutic groups requiring complicated manufacturing technologies as well as 
formulations in various dosage forms.  Indian exports are destined to more than 200 
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countries around the globe including highly regulated markets of US, Europe, Japan 
and Australia (Government of India Department of Pharmaceuticals, 2010).  The 
Government of India Department of Pharmaceuticals 2010 Report also states that 
the pharmaceutical industry is regulated by a number of acts and rules, viz. the 
Water (Prevention and Control of Pollution) Act of 1974, the Air (Prevention and 
Control of Pollution) Act of 1981, the Environment Protection Act of 1974, the 
Manufacture, Storage and Import of Hazardous Chemicals Rules of 1989, the 
Chemical Accidents (Emergency Planning, Preparedness, And Response) Rules of 
1996, the Disaster Management Act of 2005, the Public Liability Insurance Act of 
1991, the Factories Act of 1948 etc.  The Report further states that the industry is 
prone to environmental regulatory / legislation risks due to the emission of pollutants 
including toxic emissions and odour, effluents that are not easily biodegradable and 
toxic in nature, hazardous wastes that are in the form of liquids, solids, gases or 
sludges and hazards due to handling, transportation and storage of hazardous 
chemicals including warehouses, godowns, tank forms in ports/fuel depots docks. 
The Indian government promulgated the Environment (Protection) Act in 1986, which 
is the umbrella legislation to protect and improve the environment and to regulate the 
management and handling of hazardous substances and chemicals (Khanna , 
Kumar, and Kulkarni., 2010: 1).  The authors further argue that experience in India 
shows that most industries respond to environmental issues by complying with 
government regulations, but if corporations do take an antagonistic position towards 
regulations, they continue to be burdened with ever-increasing regulations and 
adverse judicial pronouncements.  According to Khanna et al. (2010: 2) hazardous 
waste in India has been defined as “any substance, excluding domestic and 
radioactive waste, which because of its quantity and/or corrosive, reactive, ignitable, 
toxic and infectious characteristics causes significant harm to human health or 
environment when improperly treated, stored, transported and disposed”.  Khanna et 
al. (2010: 2) state that in India, a comprehensive legislative framework has been in 
place for over ten years to address issues related to hazardous waste management 
but there is still a significant backlog when it comes to the implementation front. 
Khanna et al. (2010: 3) explain that the Environment (Protection) Act of 1986 
prohibits the emission or discharge of environmental pollutants in excess of 
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prescribed standards, and it also sets mandatory procedural safeguards for handling 
hazardous substances.  It has accorded wide-ranging powers to the national 
government to take all measures deemed necessary for protecting or improving the 
environment.  These powers include: 
 Laying down standards for emissions and discharges to maintain 
environmental quality; 
 Restricting the siting of industries; 
 Defining safeguards to prevent industrial accidents and concomitant remedial 
measures; 
 Laying down standards for hazardous waste management, hazardous 
chemical transport and handling, and the import and export of hazardous 
wastes and chemicals; 
 Inspection of polluting sources and direction to prevent, control and monitor 
pollution; 
 Information collection and dissemination on pollution in the country in addition 
to the governmental efforts to control pollution. 
Lastly, the rules framed by the Indian government for hazardous waste 
management under the Environmental (Protection) Act of 1986 are: 
 Hazardous Waste (Management and Handling) Rules, 1989 ( January 2000 
amendment) 
 Manufacture, Storage and Import of Hazardous Chemicals Rules,1989 
 Rules for the Manufacture, Use, Import, Export and Storage of Hazardous 
Chemicals and Genetically Engineered Organisms or Cells, 1989. 
2.4.3 Hazardous Waste (Management and Handling) Rules (1989 and 2000) 
The Hazardous Waste (Management and Handling) Rules of 1989 provide for the 
control of generation, collection, treatment, transport, import, storage and disposal of 
wastes listed in the schedule annexed to these rules.  The State Pollution Control 
Boards (SPCBs) and the state governments implement these rules, which are 
applicable to 18 categories of waste.  In order to be subject to regulation, however, 
the rules set a threshold amount of hazardous waste in each category.  No 
regulation applies at levels below the threshold. (Khanna et al., 2010: 4).  Khanna et 
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al. (2010) further elaborate that the responsibility for identification of sites for 
common treatment, storage and disposal facilities and individual toxic substance 
disposal facilities is assigned not merely to the state government, but also to the 
industrial associations responsible for the waste generation. 
The responsibilities of various authorities involved in the implementation of the 
Hazardous Waste Rules are summarised below. 
Sr. 
No. 
Activity Authority 
  MoEF SG SPCB CPCB 
1 Survey & inventorisation of HW generators and 
processors 
  X  
2 Grant authorisation for handling HW to units of 
operators 
  X  
3. Inspect facilities/infrastructures/technical 
Capabilities in HW handling units. 
  X  
4. Suspend/refuse/cancel authorisation for 
handling HW 
  X  
5. Identify and notify sites for HW treatment 
/disposal facilities 
 X X  
6. Facilities EIA studies before identifying sites  X X  
7. Collect, collate and publish list of abandoned 
HW dump sites 
 X   
8. Establish a system for filing of annual returns, 
and reporting of accidents by the HW units and 
operators 
  X  
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9. Process and grant permits for import of HW to 
units 
  X  
10. Examine and permit/refuse exporters request 
for HW import to India. 
X    
11. Issue instructions to importers of HW X    
12. Inform port authorities to take appropriate 
steps for safe handling at ports 
X  X  
13. Inspect records of imports X  X X 
14. Process appeals  X   
MoEF: Ministry of Environment and Forests; SPCB: State Pollution Control Board; SG: State 
Government; CPCB: Central Pollution Control Board. 
Table 2: Responsibilities of Authorities in India for the Implementation of Hazardous Waste 
Rules. 
2.4.4 Manufacture, Storage and Import of Hazardous Chemical Rules, 1989 
According to Khanna et al. (2010: 5) these rules have been formulated to address 
the issues involved in manufacturing, storing and importing industrial hazardous 
chemicals.  The rules specify that the occupier of the land on which hazardous 
substances will be handled is obliged to provide evidence that the major accident 
hazards have been identified and adequate steps have been taken to prevent such 
accidents and to limit their consequences to humans and the environment if they do 
occur.  Khanna et al. (2010) further mention that the occupier is requested by law to 
provide information, training, personal protective equipment and emergency 
medicine to ensure the safety of employees working within industrial premises.  The 
rules also specify strict quantities of each chemical that can be stored and request 
that these are reported to authorities, the authorities in turn have the duty to inspect 
and ask for the report on chemical being handled and on the storage details thereof. 
Indian waste legislation as identified in literature is very prescriptive but does not 
clearly define what punitive measures are in place for failure to adhere to the 
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legislation as laid out by the government. My deduction is that the laws are just 
procedural with no strict enforcement in place. 
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2.4.5 South African Waste Legislation 
To analyse current waste management practices and legislation governing waste 
management practices in South Africa and recommendations for improvement, the 
following literature was reviewed: Waste Management Practices (DEADP, 2007) 
which identify waste minimisation in terms of source reduction and recycling as 
important in waste management planning and argues that although basic measures 
are in place for waste management, there is still room for improvement; Environment 
Conservation Act 73 of 1989; National Environmental Management: Waste Act 59 of 
2008.  The National Environmental Management: Waste Act 59 of 2008 supersedes 
all waste legislation in South Africa.  According to the Waste Act 59 of 2008, waste 
generated during pharmaceutical manufacturing is defined as health care risk waste 
and the act has various rules and regulations pertaining to the segregation, 
packaging, labelling, and storing of such waste which the pharmaceutical industry 
has to stringently adhere to as follows according to the Government Gazette 
published on 1 June 2012. 
2.4.5.1 Segregation 
1) The Waste Act 59 of 2008 states that health care risk waste must be 
segregated and containerised at the point of generation. 
2) Containers must be colours coded in accordance with SANS 10248-1 (as 
amended). 
2.4.5.2 Packaging 
1) No health care risk waste must leave a generator unless contained in rigid, 
leak proof and puncture resistant containers. 
2) Any health care risk waste must be packaged in accordance with SANS 
10248-1 (as amended). 
3) Packaging for health care risk waste shall be filled to no more than three-
quarters capacity of the container. 
4) All sharps waste must be packaged in sharps containers manufactured in 
accordance with SANS 452 (as amended). 
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5) Plastic bags used as an interim storage container supported in a rigid frame 
must be in accordance with SANS 10248-1 (as amended). 
6) Plastic bags used as liners which form an integral part of a rigid container must 
be in accordance with SANS-10248-1 (as amended). 
7) All plastic bags used for the packaging of health care risk waste must be 
managed as health care risk waste and must not be reused. 
8) All plastic bags shall be closed by means of non-PVC plastic ties, non-PVC 
plastics sealing tags of the self-locking types or heat sealers purpose-made for 
health care risk waste. 
9) Anatomical waste not suitable for containerisation must be double bagged 
sealed and placed in a single-use container. 
10) Isolation waste must be double bagged, sealed and placed in a single-use 
container. 
11) Reusable containers, excluding sanitary waste bins, must be cleaned and 
decontaminated after each use in accordance with set standards as they appear 
in the annexure usually found attached to the regulations. 
2.4.5.3  Labelling 
1) All health care risk waste containers excluding interim storage containers must 
be sealed and labelled, bar coded or micro chipped to reflect the following: 
a) the date container is sealed 
b) the generator’s registration number issued in terms of Waste Information 
Regulations,2011 for major generator, or 
c) that the waste is from a minor generator. 
2.4.5.4 Storage 
Health care risk waste must be stored in designated area that- 
a) is inaccessible to unauthorised personnel and members of the public; 
b) is secured by means of suitable locks; 
c) is under cover and protected against the elements; 
d) is appropriately ventilated; 
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e) has adequate pest control measures; 
f) has access to running water and is linked to a sewer; 
g) is capable of storing clean and dirty containers separately; 
h) is clearly signposted with warning signs as to the nature of the health care 
waste being stored; and 
i) is clearly signposted with the contact details of the person in charge of the 
designated area. 
The Waste Act 58 of 2008 requires generators, transporters and waste managers to 
be in possession of relevant licensing allowing them to hold, transport and manages 
health care risk waste. 
2.4.6 Conclusion  
This section introduced the role and importance of legislation in pharmaceutical 
waste management.  Literature reviewed introduced various rules and regulations 
pertaining to waste management that are in place both in India and South Africa.  
The review of literature pertaining to Indian waste legislation was more extensive as 
the subject of the research is manufacturing plant based in India.  South African 
waste legislation, although more recent than Indian waste legislation in comparison 
seems to be more prescriptive, especially with regards to storage of health care risk 
waste and the law is very clear regarding punitive measures for non-adherence. 
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3 Section 3: Description of Research 
Methodology 
 
 
This section describes the research methodology undertaken during the research 
case study.  This includes the context and objectives of the research, assessment 
tool, data management and ethical considerations.  
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3.1 Introduction 
This section presents a description of how the work in this research was conducted.  
This is an evaluation report presented in the form of a case study which is intended 
to describe, understand and evaluate rather than predict and explain (Remenyi & 
Williams, 1996).  This section presents the research process followed in compiling 
this case study, represented by the aims and objectives, research methodology and 
design, and data collection techniques. 
3.2 Context of Research 
The DEAT (2000) White Paper on Integrated Pollution and Waste Management for 
South Africa realised the importance of introducing Integrated Pollution and Waste 
Management by adopting a paradigm shift from dealing with waste only after it is 
generated towards pollution prevention, waste minimisation, cross-media integration, 
institutional integration, both horizontal and vertical, of departments and spheres.  In 
the Draft Health Care Risk Waste Management Policy (DEAT, 2008) pharmaceutical 
manufacturers and pharmacies have been identified amongst generators of waste 
and as a result are bound to the policy which deals with healthcare risk waste, its 
management and the treatment thereof.  Although this research is on Dr. Reddy’s 
waste management at the factory in India, it will be conducted with both Indian and 
South African Waste legislation in mind to make recommendations to Dr. Reddy’s on 
which legislation needs to be upheld in order to successfully run a manufacturing 
plant in South Africa.  
3.3 Objectives of the Research 
According to Welman, Kruger, and Mitchel (2011: 193), “In hypothesis-testing 
research we deal with the general and the regular deduction.  In case studies, on the 
other hand, we are directed towards understanding the uniqueness and the 
idiosyncrasy of a particular case in all its complexity”.  Thus the aim of this research 
is to describe the concepts and theory of Waste Management and Pharmaceutical 
Waste Management in particular and determine whether waste management policies 
and practices at Dr. Reddy’s Laboratories adhere to these concepts and theories 
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.  Secondly, through the utilisation of legislative criteria and Pharmaceutical Good 
Manufacturing Practice, assess compliance of waste management practices at Dr. 
Reddy’s. 
3.4 Methodology 
The general research approach of this study is a qualitative one. The data obtained 
from the literature review has been used as a guideline for a more comprehensive 
perspective on specific waste management practices and policies at Dr Reddy’s. 
The research questions focus on how Dr Reddy’s has dealt with waste management 
issues and whether the way it has dealt with these issues has been effective 
according to their employees, or whether there is need to improve on these issues. 
The research method employed is Evaluation Research with a document analysis of 
Dr Reddy’s 2012 annual report, 2010 sustainability report and corporate literature 
against waste management processes and practices identified through literature 
reviewed. A questionnaire was also used to sample the data needed in this study on 
which employees rated the extent to which they are satisfied and understand various 
aspects of waste management practices and policies at Dr Reddy’s. 
3.5 Population and Sample Size 
Of the total population of more than 1000 employees at Dr. Reddy’s Manufacturing 
facilities at Hyderabad, India, only 100 employees were sampled for this research.  
The sample was selected using stratified random sampling and included from the 
lowest level of employees to middle managers within the factory.  The sample was 
selected to exclude those who were illiterate and could not read, write or understand 
English.  All those selected had a minimum education of grade 12, and middle 
managers had a tertiary qualification.  All the employees in the sample were 
proficient in English and were either directly or indirectly involved with waste 
management at the factory. 
3.6 Data Collection Techniques 
The data collection was performed in two phases.  The first phase was literature 
research performed over a period of time.  This stage was mainly exploratory in 
order to obtain an in depth understanding of waste management issues.  The second 
stage was the conduction of a survey through distribution of survey questionnaires.  
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One hundred questionnaires were distributed to individuals, 50 questionnaires were 
distributed to those who work directly with waste management including 
control/assurance managers, regulatory officers, superintendent pharmacists, and 
environmental officers.  The other 50 questionnaires were distributed to randomly 
selected factory employees who are not directly involved with waste management in 
order to assess their understanding of waste management processes at Dr. Reddy’s.  
The random sampling method that was used was stratified random sampling to 
include only employees with a good understanding of the English language as a 
large percentage of employees at the factory are illiterate and have difficulty 
understanding English.  In total a response rate of 61% was realised with 61 of the 
100 questionnaires being returned for the purpose of the analysis.  Of the 61 
questionnaires, the majority were from those directly involved with waste 
management (43) and 18 were from general factory employees not involved with 
waste management.  The theory that was discussed in the literature review section 
provided the framework for the data required from the questionnaire 
The design and content of the research questions were informed by theoretical 
methods of management of pharmaceutical waste as determined through review of 
literature and by criteria set in Waste Legislation of both South Africa and India. 
The survey questionnaires were drawn up from previous research reviewed in 
literature review including waste management criteria set by Department of 
Environmental Affairs and Development Planning (2007) in South Africa. 
The detailed questionnaire is in Appendix A. 
3.7 Data Analysis 
The informative data collected during the interview sessions was utilised to create 
the background and detail narrative to understand pharmaceutical waste 
management processes that were implemented and followed at Dr. Reddy’s 
manufacturing facilities in Hyderabad, India. 
The survey incorporated questions from each of the four main areas of waste 
management viz. Waste Minimization, Waste Recycling, Waste Re-use, and Waste 
Disposal.  The data obtained following administration of the questionnaires was 
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presented in the simple percentage of the numbers that responded to each interview 
question. 
3.8 Ethical Considerations 
Permission has been granted by Dr. Reddy’s Laboratories Head Office in India to the 
researcher to carry out the research and conduct aforementioned interviews.  The 
researcher is in the employ of Dr. Reddy’s Laboratories as a Product Manager, thus 
the researcher was from the onset aware of concerns relating to subjectivity, 
confidentiality, and bias.  The principles underlying ‘research ethics’ are universal 
and concern issues such as honesty and respect for the rights of the individuals 
(Welman et al., 2005). 
According to Welman et al. (2005), ethical considerations come into play at three 
stages of the research project, namely: 
 When the participants are recruited. 
 During intervention and/or the measurement procedure to which they are 
subjected. 
 In the release of the results obtained. 
In lieu of the above and to avoid unethical practices, the researcher used as a 
guideline Bassey’s (1999) three principles of ethical practice drawn from case study 
research which ensured effective governance and ethical behaviour through the 
research: 
Respect for persons: This ensured that respondents understood the questions, the 
rationale to partake in the research, and the right to privacy. 
Respect for democracy: Each respondent was explained the role and type of the 
research conducted and was given the opportunity to withdraw from the study, as 
well as assured confidentiality at all times. 
Respect for truth: The researcher ensured that the research was conducted, 
examined and reported with rigour and depth to ensure validity of the findings. 
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3.9 Conclusion 
According to the interview and survey participants, research of this nature has never 
been undertaken at Dr Reddy’s Laboratories.  The result and ensuring 
recommendations will create awareness of what needs to be improved in terms of 
waste management policies and practices as the organisation moves forward and 
expands its manufacturing facilities into South Africa.  The results of the survey data 
are presented and commented on to provide an overall assessment of waste 
management practices based on criteria set by Waste Management Legislation and 
Pharmaceutical Waste Management Guidelines. 
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Appendices 
3.11 Appendix A.  The Research Questionnaire 
This interview is based on a series of questions compiled by the researcher to gain an 
understanding of the Waste Management Processes adopted at Dr Reddy’s Laboratories. 
The contents of your input are treated as confidential and are for academic research 
purposes only. 
Question 1: 
Why do you believe there is a need for a Waste Management Strategy for Dr. Reddy’s? 
 
 
 
Question 2: 
What Waste Management Processes are currently being implemented at Dr. Reddy’s? 
 
 
 
Question 3: 
Which specific Act in Indian Waste Legislation regulates pharmaceutical waste? 
 
 
 
Question 4: 
How does Dr. Reddy’s ensure Waste Minimisation in its manufacturing processes? 
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Question 5: 
What recycling and re-use measure are in place at Dr Reddy’s manufacturing plants? 
Please select only one option per question from below to indicate your recommendations: 
 
UNDERSTANDING OF WASTE MANAGEMENT PRACTICES AMONGST DR REDDY’S 
EMPLOYEES 
 There is limited awareness of Waste Management Practices 
 There is limited understanding of Waste Management Practices 
 Casual and ad hoc 
 Regular, clear – training departmental awareness 
 There is emerging awareness and adoption of Waste Management Practices. 
 
WHICH OF THE FOLLOWING IN YOUR OPINION NEED TO BE IMPROVED 
 Waste Minimization 
 Waste recycling 
 Waste re-use 
 Waste Disposal 
 None of the above, Dr Reddy’s is on par with other pharmaceutical companies in 
India. 
 
PLEASE SELECT THE TOP TWO IDEAS YOU BELIEVE WOULD IMPROVE THE 
LEVELS OF THE ADOPTION OF WASTE MANAGEMENT PRACTICES BY STAFF AT 
DR. REDDY’S 
 
 Annual Employee Satisfaction Survey 
 Departmental Committees to oversee Waste Management projects, processes and 
operational issues. 
 Ongoing staff training on Waste Management processes 
 None of the above. 
 
 
THANK YOU FOR YOUR VALUED PARTICIPATION!!! 
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3.12 Appendix B. DR. REDDY’S SOP FOR HANDLING OF 
HAZARDOUS WASTE. 
 
FonwJations 
Unit II 
• r-y DR.R.EDDY·S 
STANDARD OPERATING PROCEDURE 
Title: HandJiDg, Storage and Disposal of Haurdous Waste 
SOP NO: rnSAOO9-OO Department: Safety, Health & STAMP Ilffill!.E Environment 
EfffCti,.. Datt: Page No.: lof5 
1.0 OBJECID'E 
To lay down the procedure for Haodling, Storage and Disposal of Ha2ardols Waste 
generated 
2.0 SCOPE 
This procedure is applicable to Formu1ations Unit II for Handling, Storage and 
Disposal of Hazardous Waste genented within the factory and waste reoei\...! from 
C&F Agents of Dr. Reddy's Laboratories Limited. 
3.0 RESPONSmILlTY 
3.1 SHE Incharge for coordinating & ooutrolling procedure. 
3.2 SHE Jucbarge for Handling & Safe Disposal of Hazardous Waste 
3.3 HOD-SHE for compliance of the procedure 
4.0 DEFINITIO. 
Not applicable 
5.0 PROCEDURE 
5.1 GENERAL PRECAUTIONS DURING HAZARDOUS WASTE lL-\NDLlNG 
5.LI All the operators shall wear safety sboes, hand gloves & appropriate dust mask during 
hazardous waste handling. 
5.1.2 Wbile handling rejected & waste solvents earthing of container shall be ensnred for 
static charge dissipation & operators shall wear solveot absDlbing half face masks. 
5.13 A1Iy kind of spillages shall be ",'Oded dnriDg bandling of hazardous waste. 
5.1.4 Hom:dons waste handling shall be carried out by authorizEd persons only. 
5.1.5 Hazardous waste bandling area shall have Joc1: & key provision & shall be opened only 
by anthorizEd person 
5.1.6 Different waste categories shall not be mi:<ed together. 
PREPARED BY REVIEWED BY APPROVED BY 
User Head of the Department Quality Assnrance 
Sign: Sign Sign: 
Date: Date: Date: 
FTCQAOOIIFOI-OO 
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• Formulations 
Unitll 
r--y DR.R.EDDY'S 
STANDARD OPERATING PROCEDURE 
Title: Handling, Storage and Disposal of Hazardous Waslf 
SOP NO: Ff2SAOO9-OO Department: Safety, Health & 
EnviroDJDeDl 
Ef{ectiTe Dalf : Page No: 200 
5.2 RECIEPT, TREAlMENT & STORAGE OF HAZARDOUS WASTE DATE 
EXPIRED, DISCARDED, OFF SPECITICATIO. DRUGS & MEDICINES (HW 
CATEGORY - 28.3, 28.4) 
5.2.1 This category includes rejects recei\oed nom Ol3Illlflcturiog (In process rejected I waste 
tablets, capsules, blends, pellets, Solid IlIW material, Exciq>ients, Startup rejects, etc), 
rejected raw material from RM Warebouse & rejected finished goods nom FG warehouse, 
Date expired medicines and drugs from Material Receiving Godown. 
5.2.2 Collect Rejects I waste nom manufacturing and Date expired drugs and medicines from 
MRG after Reciept, Segregation and De1itcing as per SOP Ff2SAOO4 along with doly 
filled disposal request as per FTCSA0201 AOI 
5.23 An the rejects received nom manufacturing shall be de labeled & stored in designated 
place 
5.2.4 The waste recei,oed from RM warehouse shall be repacked in poly bags & containers and 
shall be sent fur de labeling & detoxification. 
5.25 The material received nom FG warehouse shall be defuiled m:ulIlilly to segregate tablet, 
capsoles & empty blisters, bottles, papers and shall be hand 0''': to scnp yard fur disposal 
5.2.6 The Tablets & capsules shall be crushed in crushing machine and send to Hazardous waste 
stonge area alo"ll with dnly filled disposal reqoest as per FTCSA020l AOI 
5.2.7 The blends, pellets, powders alo"ll wilh Crushed I powdered material shall be packed into 
double poly bags. 
5.2.8 An Bags shall be stored in designated place at Hazardous Waste storage area fur disposal 
and eDSUre 00 spillage ofpowderlliquid on floor. 
5.3 RESIDUES & WASTE (HW CATEGORY - 28.1) 
5.3.1 This category includes waste generated I rejected coating sohItion from pOOuctioD, boiler 
soot from utility, water treatment resins from water systems, dust & powder from HVAC 
filters, dry dust scrubbers from mechanical department. 
5.3.2 Collect the waste from generator alO"ll with dnly filled disposal request as per the 
FTCSA0201AOI 
5.3.3 The reject coating sohrtion shall be stored in poly bags OR refilled in 200 Itrs capacity 
HDPEdrums. 
5.3.4 Coating solution baodting shall be """",ted in designated area. As these may contain 
solvent, proper safety p<ecautions ,hall be taken. 
PREPARED BY REVIEWED BY APPROVED BY 
User Head of the Department Quality Assonnce 
SiIm; SiIm; SiIm; 
Date: Dilte: Date: 
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r-y DR.R.EDDY'S 
STANDARD OPERATING PROCEDURE 
Title: Handling, Storage md Disposal o(Hazardous Wast. 
SOP NO: FT2SAOO9-OO Department: Safety, Health & 
EnviroDJDeDt 
Efftcti,.. Datr : Pag. No: 300 
53.5 Boiler soot shall be repacked in poly bags & stored in designated area fur disposal 
53.6 Water lrea_1lI resins sball be stored in drum; in designated area fur ctisposal 
53.7 All the coillainers iihall be labeled with appropriate Hazardous waste sticker on it 
5.4 SPENT ORGAI'<lC SOLVENTS (HW CATEGORY - 28.5) 
5.4.1 This category includes waste organic solveDls from Production, Pilot Plants & Quality 
Comol Labs. 
5.4.2 Receive the waste along with disposal request a. per FICSA0201 AOI. 
5.4.3 All the waste shall be refilled in 200 1m capacity IIDPE drums along with 28.1 category 
waste in designated area 
5.4.4 All the containers iihall be labeled with appropriate Huardous waste sticker on it. 
5.5 IIDPE CHEMICAL CO(l;TAINERS & LINERS (HW CATEGORY - 33.3) 
5.5.1 This category includes empty solvell! drums, raw material storage containers & liners. 
5.5.2 Detoxification and Storage should be done as per SOP: FT2SAOO7 
5.6 ETP SLUDGE (HW CATEGORY - 3~.3) 
5.6.1 This category includes sludge generated from ETP through drying beds. 
5.6.2 Shldge collected from dr)oing beds then packed in polythene co"ers 
5.6.3 All polythene bags stored in designated place at Huardous waste storage area fur disposal 
5.7 WASTE I USED OIL (HW CATEGORY - 5.1) 
5.7.1 This category includes waste I used oil from oil fi:red boilers & air compressors in utility, 
waste diesels from generators, machine oils & grease wastes from concerned area. 
5.7.2 Waste oils iihall be collected from concerned area with disposal request & refilled in 
designated IIDPE drums stored in designated place for disposal with sorely precanlions. 
5.8 OTHER HAZARDOUS WASTE 
5.8.1 This includes Used! waste batteries, thennacoal, etc 
5.81 Thermacol sbaII be received & stored in designated place fur disposal 
5.8.3 UsedlLead acid ba.tleDe, shall be stored in designated places for disposal 
5.9 BIO·MEDICAL WASTE 
5.9.1 This includes biomedical waste from Microbiology laboratory & Occupational Health 
Cenler 
5.9.2 It shall be Segregated, Stored and Disposed as per SOP: FT2SA008 
PREPARED BY REVIEWED BY APPROVED BY 
User Head of the lJep~1lI [JuaJity Assurance 
SiJ:nc Si2;n: SiJlo:. 
Date: Dilte: Date: 
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ry DR.RHDDY·S 
STANDARD OPERATING PROCEDURE 
Tilk: HaDdtiDg, Storage aDd Disposal of Hazardous Waste 
SOP NO: Ff2SAOO9-OO Department: Safety, Health & 
Environment 
Effft'tin.' Datt" : Page No: 40f5 
5.10 DISPOSAL or HAZARDOUS WASTE 
5-10.1 All the wastes from HW category No. 28-1, 28.3, 28.4, 28.5, 34.3 shall be disposed 
periodically to Hazardous Waste Managemelll Project ~), DundigaI OR Cement 
Industry through an ogreemenI as per CFO conditions by Andhn Pndesh Pollntion CoDlrnI 
Board. 
5-10.2 The waste consignments shall be accompanied byTREM card & FORM 13 (6 copy 
manifest) as per requiremelll of Hazardous waste management rules, 2008 of Government 
of India. 
5-10.3 DetoJtified drums & liners shall be haDdover to scrap yard for disposal. 
5.10.4 WweJ Used Oil shall he disposed to mthoriz.ed recyclers through an agreement along with 
TREM card & FORM 13 (6 copy manifest) . 
5-10.5 WweJ Used batteries shall he handed o"er to manmacturer I dealer on hny back policy or 
disposed to CPCB (Central Pollution CoDlrnI Board) approved recyclers wide an agreement 
as per The batteries Management & Hand.ling rules, 2001 ofGo\'5Ilme1ll of India. 
5-10.6 Bic>-Medical Waste shall be disposed periodically to APPCB approved filcility as per 
Biomedical waste management & hand.ling rules, 1998 of Go\'5Ilme1ll oflndia along with 
manifest copy through an agreemelll 
6.0 REFERLNCE(s) 
SOP no. (CtmenI Version) Trtle 
FTCSA020 Procednre fur rec~t \rea_Ill and 
disposal ofsolidlliquid wwes 
FTISAOO4 Rec~t, Segregation, Defacing and 
Disposal of Expired, Discarded and Off· 
~caticn edicines 
FTISA007 Procednre fur Detoxification of EIq>ty 
Colllame.s and liners 
FTISA008 Rec~t, Segregation and Disposal of 
Bio Medical Waste 
PREPARED BY REVIEWED BY APPROVED BY 
User Head of the Dep~1lI Quality Assurance 
Sign: Sign: Sign: 
Date: Date: Date: 
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STANDARD OPERATING PROCEDURE 
Tilk: HaDdtiDg, Storage aDd Disposal of Hazardous Waste 
SOP NO: Ff2SAOO9-OO Department: Safety, Health & 
Environment 
Effft'tin.' Datt": Page No: 5 of5 
7.0 ABBRLVIA nONe,) 
I FoB . 
SOP I( 
No. 
EIP • PlaJJI 
LK 1LoIIYS 
IJl: 
SCM I Supply~ 
TSDF I Facilitv 
SS , Steel 
MKli 
H\V ; Waste 
q() L QlnseDl For I 
~card • Card 
I Andhr.o Pradesh . L Como! Board 
(;&10. AgeD! : AgeD! 
8.0 FLOWCHART(,) 
Not Applicable. 
9.0 A.~"URE(,) 
Not Applicable. 
PREPARED BY REVIEWED BY APPROVED BY 
User H.ad of the DepartmeDl Quality Assurance 
Sign: Sign: Sign: 
Dat. : Date: Date: 
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